This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Thyrotoxicosis, other and/or unspecified
E4_THYTOXNAS
Thyrotoxicosis: A hypermetabolic syndrome caused by the elevation of thyroid hormone levels in the serum. Signs and symptoms include tachycardia, palpitations, tremor, weight loss, warm weather intolerance, and moist skin. Causes include Graves disease, toxic nodular goiter, toxic thyroid nodule, and lymphocytic thyroiditis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
8986 |
4. Check minimum number of events
Min. number of events
3
|
8986 |
5. Include endpointsNone |
8986 |
6. Filter based on genotype QC (FinnGen only) |
8986 |
Control definitions (FinnGen only)
- Control exclude
- E4_THYROID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Thyrotoxicosis, other and/or unspecified
based on the number of shared cases.
Similar with more cases:
- Thyrotoxicosis
- Disorders of thyroid, IBD co-morbidities
- Disorders of the thyroid gland
- Used for control exclusion in common control thyroid runs
- Endocrine, nutritional and metabolic diseases
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 8986 | 7039 | 1947 |
| Unadjusted period prevalence (%) | 2.07 | 2.40 | 0.86 |
| Median age at first event (years) | 53.33 | 51.46 | 60.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 7934
- Matched controls
- 79340
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
11811.3
323.0
4198
7
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
1724.6
323.0
1035
7
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
39.0
323.0
415
112
T85
ICPC
Hyperthyroidism/thyrotoxicosis
197.8
323.0
341
18
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
377.6
323.0
954
29
104
Kela drug reimbursment
Thyroid insufficiency
917.0
323.0
1672
23
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
33.9
323.0
568
180
H03AA01
ATC
levothyroxine sodium; systemic
123.7
323.0
4741
939
E03.89
ICD-10 Finland
Other specified hypothyroidism
139.0
323.0
471
36
BAA60
NOMESCO Finland
Total thyroidectomy
1148.4
323.0
1259
13
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
1517.3
323.0
559
*
C07AA05
ATC
propranolol; systemic
4.4
323.0
2945
9326
H03BB01
ATC
carbimazole; oral
3756.6
323.0
6207
71
E05.89
ICD-10 Finland
Other thyrotoxicosis
2006.1
323.0
402
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
4099.2
323.0
4400
24
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
560.4
323.0
855
17
C07AB07
ATC
bisoprolol; oral
2.7
323.0
4149
23148
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
323.0
677
*
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
+∞
323.0
829
*
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
2002.8
323.0
855
5
T86
ICPC
Hypothyroidism/myxoedema
66.7
323.0
501
80
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
123.5
323.0
1404
138
E03
ICD-10 Finland
Other hypothyroidism
70.1
323.0
639
99
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.2
277.2
805
1424
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
2295.4
241.6
233
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
28.6
239.2
330
120
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
2242.8
236.4
228
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
109.6
214.4
234
22
C01BD01
ATC
amiodarone; systemic
8.8
209.5
470
563
H062, E050
ICD-10 Finland
NA
+∞
196.6
188
*
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
+∞
189.3
181
*
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
22.4
173.0
256
118
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
15.9
152.1
254
165
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
144.9
2780
17240
H03BA02
ATC
propylthiouracil; oral
+∞
136.8
131
*
24220
ICD-8 Finland
Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre
+∞
129.5
124
*
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
633.1
126.7
125
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.1
124.3
419
865
E05.4
ICD-10 Finland
Thyrotoxicosis factitia
+∞
121.1
116
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.1
117.1
1517
7919
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
116.9
3319
23029
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
30.5
111.1
150
50
TFP20
NOMESCO Finland
Cardiodefibrillation
3.3
110.3
617
2005
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
97.3
104.2
115
12
E06.1
ICD-10 Finland
Subacute thyroiditis
+∞
103.3
99
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
48.0
100.6
123
26
E06.3
ICD-10 Finland
Autoimmune thyroiditis
44.6
99.2
123
28
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
67.0
91.7
106
16
207
Kela drug reimbursment
Chronic arrhythmias
2.2
91.1
1012
4880
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
111.4
91.1
99
9
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
15.8
89.6
149
96
H05.2
ICD-10 Finland
Exophthalmic conditions
36.5
83.7
108
30
E05.5
ICD-10 Finland
Thyroid crisis or storm
+∞
83.5
80
*
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
26.5
82.3
115
44
H02AB06
ATC
prednisolone; systemic
1.6
79.9
3455
25995
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
+∞
78.2
75
*
C07AB02
ATC
metoprolol; systemic
1.8
76.6
1448
8571
E06.9
ICD-10 Finland
Thyroiditis, unspecified
56.9
76.0
90
16
C07AA07
ATC
sotalol; systemic
3.7
72.0
338
953
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
70.3
2938
21697
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
+∞
65.7
63
*
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
+∞
62.6
60
*
B01AA03
ATC
warfarin; systemic
1.8
61.0
1205
7178
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
+∞
60.5
58
*
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.0
59.6
895
4840
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
57.0
1587
10452
C03CA01
ATC
furosemide; systemic
1.6
56.1
1715
11571
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
+∞
55.3
53
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.5
54.5
168
313
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
5.4
54.3
169
319
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
9.0
54.0
117
132
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
54.0
1342
8548
E06.4
ICD-10 Finland
Drug-induced thyroiditis
+∞
51.1
49
*
A11CC03
ATC
alfacalcidol; systemic
4.3
50.9
195
459
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.9
50.8
771
4174
A02BC02
ATC
pantoprazole; systemic
1.4
50.6
4647
39433
R00.2
ICD-10 Finland
Palpitations
2.1
50.2
586
2852
TFP34
NOMESCO Finland
Electrophysiological investigation
3.4
49.9
256
775
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
49.8
1110
6831
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
+∞
49.0
47
*
C01AA05
ATC
digoxin; systemic
2.3
48.7
496
2267
CA1AD
NOMESCO Finland
Orbita CT
27.0
48.5
67
25
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
480.7
48.4
48
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
48.3
750
4090
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
47.9
1060
6504
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.4
45.9
417
1803
R53
ICD-10 Finland
Malaise and fatigue
1.6
45.6
1408
9458
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.8
45.4
831
4793
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
44.4
1842
13254
106
Kela drug reimbursment
Hypoparathyroidism
28.8
44.3
60
21
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
2.4
44.1
395
1694
N02BE01
ATC
paracetamol; systemic, rectal
1.5
43.5
6445
58936
H53.2
ICD-10 Finland
Diplopia
3.0
43.2
256
860
R94.6
ICD-10 Finland
Abnormal results of thyroid function studies
13.2
43.0
76
58
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
42.5
745
4232
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
42.5
1391
9459
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
38.1
41.8
53
14
C01BC04
ATC
flecainide; systemic
2.9
41.7
269
957
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
41.1
1106
7149
TFP35
NOMESCO Finland
Electroanatomical mapping
4.8
40.9
140
295
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.5
39.9
326
1331
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
5.0
39.7
130
261
H50.2
ICD-10 Finland
Vertical strabismus
6.9
39.7
101
148
I47.2
ICD-10 Finland
Ventricular tachycardia
3.8
39.3
171
454
E83.51
ICD-10 Finland
Hypocalcemia
11.0
38.9
75
69
H03BB02
ATC
thiamazole; oral
137.3
38.7
41
*
XF404
NOMESCO Finland
Ambulatory ECG
1.9
38.1
611
3359
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
37.7
1866
13849
ZXA10
NOMESCO Finland
Bilateral
1.5
36.6
1246
8523
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.4
36.0
308
1291
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
180.7
34.8
36
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
34.7
2744
22107
CAC44
NOMESCO Finland
Combined decompression of orbit
+∞
34.4
33
*
H02AB07
ATC
prednisone; oral
1.6
33.8
975
6392
C03DA01
ATC
spironolactone; oral
1.8
33.8
631
3651
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
32.5
1131
7751
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.4
32.2
280
1184
R06.0
ICD-10 Finland
Dyspnoea
1.4
32.0
1547
11371
K80
ICPC
Cardiac arrhythmia NOS
1.9
31.5
500
2736
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
30.8
692
4232
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.1
30.8
375
1855
H02AB09
ATC
hydrocortisone; systemic
3.4
30.6
151
446
B01AF02
ATC
apixaban; oral
1.8
30.6
555
3179
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.5
29.7
249
1033
K04
ICPC
Palpitations/awareness of heart
2.1
29.6
366
1820
K78
ICPC
Atrial fibrillation/flutter
1.9
29.6
427
2258
ZX120
NOMESCO Finland
Intravenous
1.7
29.3
622
3741
XCK00
NOMESCO Finland
Perimetry
1.9
29.2
444
2391
2423X
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre, unspecified
+∞
29.2
28
*
WX402
NOMESCO Finland
General anaesthesia
1.5
29.2
1096
7631
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
29.1
1347
9795
SPAT1262
SPAT
Handing over of treatment supplies
1.5
29.0
1055
7292
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.8
28.2
186
673
E07.9
ICD-10 Finland
Disorder of thyroid, unspecified
18.8
28.2
43
23
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.9
27.8
425
2294
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
27.2
1618
12315
R03AC02
ATC
salbutamol; inhalant
1.3
26.8
3651
31488
J01DB01
ATC
cefalexin; oral
1.3
26.7
5947
54867
H04AA01
ATC
glucagon; nasal, parenteral
2.9
26.5
165
577
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
5.7
26.4
77
137
T89
ICPC
Diabetes insulin dependent
2.4
26.1
234
1005
E05.3
ICD-10 Finland
Thyrotoxicosis from ectopic thyroid tissue
+∞
26.0
25
*
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
25.6
598
3694
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.7
25.3
177
665
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
25.1
1531
11674
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
25.0
24
*
M14.5*E03.9
ICD-10 Finland
Arthropathy in hypothyroidism (E00-E03+)
+∞
25.0
24
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
24.9
1992
15879
WX110
NOMESCO Finland
Local anesthesy
1.3
24.8
4881
43980
CAC20
NOMESCO Finland
Lateral decompression of orbit
250.9
24.7
25
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
24.4
2396
19674
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.1
24.3
293
1444
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.8
24.2
160
579
B01AB05
ATC
enoxaparin; parenteral
1.3
24.1
1934
15412
AA1AD
NOMESCO Finland
CT of head and brain
1.4
23.8
1365
10293
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.2
23.7
250
1163
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
87.0
23.6
26
*
A04
ICPC
Weakness/tiredness general
1.5
23.6
811
5515
C09AA05
ATC
ramipril; oral
1.4
23.4
1328
9991
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
23.1
784
5319
24209
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffuse NUD
+∞
22.9
22
*
M14.5*E05.9
ICD-10 Finland
Arthropathy in thyrotoxicosis [hyperthyroidism]
+∞
22.9
22
*
SPAT1263
SPAT
Sampling
1.3
22.8
2822
23859
I50.1
ICD-10 Finland
Left ventricular failure
2.2
22.8
236
1089
O90.5
ICD-10 Finland
Postpartum thyroiditis
83.7
22.7
25
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
22.6
3765
33026
A10AE04
ATC
insulin glargine; parenteral
1.7
22.1
489
2971
G73.0*E05.9
ICD-10 Finland
Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]
+∞
21.9
21
*
E05.8
ICD-10 Finland
Other thyrotoxicosis
+∞
21.9
21
*
A11CC02
ATC
dihydrotachysterol; oral
15.3
21.4
35
23
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
5.5
21.3
63
115
J01AA02
ATC
doxycycline; systemic
1.3
21.3
5578
51525
H50.8
ICD-10 Finland
Other specified strabismus
17.4
21.3
33
19
XF402
NOMESCO Finland
ECG with work load test
1.6
21.2
605
3936
N05BA04
ATC
oxazepam; oral
1.3
21.2
1614
12718
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
21.0
1797
14408
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
24.2
20.8
29
12
H50.6
ICD-10 Finland
Mechanical strabismus
24.2
20.8
29
12
A02BC01
ATC
omeprazole; systemic
1.3
20.7
1725
13771
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.7
20.6
144
543
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
9.0
20.5
43
48
A02BC05
ATC
esomeprazole; systemic
1.3
20.4
2658
22520
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.7
20.4
421
2508
AR6
HP
Catheter ablation of arrhythmia, target: atrial fibrillation
7.1
20.2
49
69
I50.0
ICD-10 Finland
Congestive heart failure
1.8
20.2
336
1870
T81
ICPC
Goitre
10.9
20.1
38
35
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
20.0
1072
7962
A10AE05
ATC
insulin detemir; parenteral
1.9
20.0
309
1674
N05CF01
ATC
zopiclone; oral
1.3
20.0
2014
16499
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
19.8
3442
30154
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
19.8
1284
9852
GB1AA
NOMESCO Finland
Tracheal X-ray examination
73.6
19.7
22
*
E06.0
ICD-10 Finland
Acute thyroiditis
24.6
19.5
27
11
I48.1
ICD-10 Finland
Persistent atrial fibrillation
2.5
19.4
151
605
WX892
NOMESCO Finland
Monitored bed care
1.7
19.2
428
2604
AQ2
HP
Electrophysiological electroanatomical examination
6.8
19.2
48
71
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
3.1
19.1
107
351
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
20.1
19.0
28
14
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.1
18.8
215
1039
E03.82
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
+∞
18.8
18
*
2429X
ICD-9 Finland
Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre or other cause
70.0
18.7
21
*
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
6.0
18.7
51
85
342
Kela drug reimbursment
Dronedarone
4.4
18.6
68
157
K90.0
ICD-10 Finland
Coeliac disease
2.2
18.6
192
888
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.2
18.6
195
909
E05.81
ICD-10 Finland
Overproduction of thyroid-stimulating hormone
190.4
18.5
19
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
18.5
960
7083
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
18.4
1015
7572
N02AX02
ATC
tramadol; systemic, rectal
1.3
18.3
2621
22387
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
4.9
18.3
59
120
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
18.0
1077
8143
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.8
17.9
114
406
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
17.9
1503
11977
2504
FHL
Unilateral resection or enucleation
10.7
17.9
34
32
R11
ICD-10 Finland
Nausea and vomiting
1.6
17.7
483
3105
CEC00
NOMESCO Finland
Recession of extraocular muscle
6.0
17.6
48
80
A10AA01
ATC
NA
2.3
17.6
166
734
K02.1
ICD-10 Finland
Caries of dentine
1.2
17.5
3809
34035
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
17.4
3222
28287
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
17.4
437
2751
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
17.3
1008
7586
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
17.2
916
6782
I47.1
ICD-10 Finland
Supraventricular tachycardia
1.9
17.0
259
1401
SPAT1097
SPAT
Recording of ECG
1.4
16.9
828
6040
E07.89
ICD-10 Finland
Other specified disorders of thyroid
25.6
16.9
23
9
SPAT1301
SPAT
No procedures
1.3
16.9
1943
16132
Z01.7
ICD-10 Finland
Laboratory examination
1.5
16.8
663
4638
R50.9
ICD-10 Finland
Fever, unspecified
1.4
16.8
783
5660
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
16.7
3408
30181
24200
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi
+∞
16.7
16
*
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
16.6
349
2092
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
16.6
279
1561
TFP47
NOMESCO Finland
Ablation or modification of the AV-node
5.1
16.6
52
103
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
16.6
679
4786
E03.8
ICD-10 Finland
Other specified hypothyroidism
90.2
16.5
18
*
B01AF01
ATC
rivaroxaban; oral
1.5
16.5
612
4228
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
16.4
4916
45278
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.6
16.3
392
2439
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.5
16.1
128
522
E20.8
ICD-10 Finland
Other hypoparathyroidism
30.1
16.1
21
7
C01BD07
ATC
dronedarone; oral
4.6
16.1
55
120
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
16.0
2093
17623
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
16.0
765
5554
H3600, E103
ICD-10 Finland
NA
3.3
16.0
80
244
N06AX11
ATC
mirtazapine; oral
1.3
15.8
1976
16546
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
60.1
15.7
18
*
N05AN01
ATC
lithium; oral
2.4
15.7
131
547
R13
ICD-10 Finland
Dysphagia
1.7
15.7
338
2039
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
+∞
15.6
15
*
BA1AN
NOMESCO Finland
Thyroid gland isotope imaging
+∞
15.6
15
*
E89.9
ICD-10 Finland
Postprocedural endocrine and metabolic disorder, unspecified
+∞
15.6
15
*
J01CA04
ATC
amoxicillin; systemic
1.2
15.6
5848
54983
R60.0
ICD-10 Finland
Localized oedema
1.5
15.6
609
4248
I49.5
ICD-10 Finland
Sick sinus syndrome
2.0
15.5
187
926
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.8
15.5
98
351
G47.3
ICD-10 Finland
Sleep apnoea
1.3
15.5
1060
8175
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
160.3
15.5
16
*
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.6
15.5
109
416
E04.8
ICD-10 Finland
Other specified nontoxic goitre
13.7
15.5
26
19
AQ1
HP
Conventional electrophysiological examination
3.2
15.4
81
256
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
15.4
1357
10859
A10AA02
ATC
NA
2.0
15.4
190
950
Z71.8
ICD-10 Finland
Other specified counselling
1.3
15.3
1510
12268
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
15.3
747
5444
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
2.7
15.2
104
390
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
2.5
15.1
117
470
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
45.1
15.0
18
*
R06AE07
ATC
cetirizine; oral
1.2
14.9
2995
26380
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
14.9
296
1745
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
14.8
1436
11631
R63.4
ICD-10 Finland
Abnormal weight loss
2.0
14.7
189
960
R02
ICPC
Shortness of breath/dyspnoea
1.4
14.7
672
4839
R51.80
ICD-10 Finland
Headache
1.4
14.6
899
6817
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
14.6
14
*
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
2.1
14.5
167
811
L28
ICPC
Limited function/disability (L)
1.4
14.4
845
6353
R01AD08
ATC
fluticasone; nasal
1.3
14.4
1831
15333
C08CA01
ATC
amlodipine; oral
1.2
14.4
1921
16179
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
14.3
2966
26175
R42
ICD-10 Finland
Dizziness and giddiness
1.3
14.3
1274
10205
WX002
NOMESCO Finland
Sedation and analgesia
1.3
14.2
1162
9196
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
14.2
1137
8970
M25.5
ICD-10 Finland
Pain in joint
1.3
14.1
1788
14957
J01FA10
ATC
azithromycin; systemic
1.2
14.1
4044
36798
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
14.1
1830
15351
M79.6
ICD-10 Finland
Pain in limb
1.2
14.0
2255
19377
J01DA01
ATC
[U] cefalexin; systemic
1.2
14.0
4331
39689
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
4.1
14.0
53
129
R07.0
ICD-10 Finland
Pain in throat
1.6
13.9
353
2230
UJF32
NOMESCO Finland
Coloscopy
1.3
13.9
1482
12140
SPAT1255
SPAT
Intravenous administration of medicine
1.6
13.9
343
2154
AN1
HP
Coronary angiography
1.5
13.8
529
3676
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.1
13.7
152
726
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
13.7
2571
22437
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
13.7
946
7304
C09DX04
ATC
valsartan and sacubitril; oral
4.3
13.6
49
114
2411A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic multinodular goitre
+∞
13.5
13
*
K29.4
ICD-10 Finland
Chronic atrophic gastritis
2.4
13.5
108
445
2AB04
NOMESCO Finland
NA
7.1
13.5
32
45
WF099
NOMESCO Finland
Other radiotherapy
4.7
13.4
45
97
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
4.5
13.4
47
106
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.5
13.4
402
2649
R03BB04
ATC
tiotropium bromide; inhalant
1.5
13.4
477
3264
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
25.8
13.3
18
7
R01AD09
ATC
mometasone; nasal
1.2
13.3
3011
26736
CA1BD
NOMESCO Finland
Extensive orbita CT
13.8
13.2
22
16
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
3.9
12.9
52
134
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
12.9
918
7115
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.2
12.8
1594
13287
E50.0
ICD-10 Finland
Vitamin A deficiency with conjunctival xerosis
50.1
12.8
15
*
SGA01
NOMESCO Finland
Tooth opening as first aid
1.3
12.7
930
7235
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
12.7
1418
11675
N03AX16
ATC
pregabalin; oral
1.3
12.7
1379
11313
GD1LA
NOMESCO Finland
GD
2.7
12.7
85
318
1CX08
NOMESCO Finland
NA
6.0
12.7
34
57
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
12.6
309
1933
C08DA01
ATC
verapamil; systemic
1.8
12.6
230
1324
WX290
NOMESCO Finland
Other blockade of nerve
1.2
12.6
2841
25190
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
12.5
419
2830
B81
ICPC
Anaemia vit B12/folate deficiency
1.9
12.5
178
941
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.5
12.5
456
3137
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.5
12.4
504
3543
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
130.2
12.4
13
*
SPAT1312
SPAT
General health counselling
1.2
12.4
2013
17272
H3601, E103
ICD-10 Finland
NA
3.3
12.4
60
181
M54.5
ICD-10 Finland
Low back pain
1.2
12.2
2048
17619
TFP44
NOMESCO Finland
Ablation treatment of typical atrial flutter
3.5
12.2
56
162
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
12.1
439
3017
A10AE06
ATC
insulin degludec; parenteral
2.0
12.0
147
737
H50.0
ICD-10 Finland
Convergent concomitant strabismus
3.6
12.0
52
144
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.4
11.9
602
4413
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
3.1
11.9
65
214
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
11.9
1798
15298
E06
ICD-10 Finland
Thyroiditis
46.7
11.9
14
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
11.9
399
2700
CEW99
NOMESCO Finland
Other operation on extraocular muscle
10.5
11.7
22
21
H57.1
ICD-10 Finland
Ocular pain
1.8
11.7
185
1017
AR5
HP
Catheter ablation of arrhythmia, target: atrial flutter
6.6
11.7
29
44
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
11.7
2871
25602
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
11.6
2285
19952
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
11.6
846
6580
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
11.5
697
5267
24110
ICD-8 Finland
Non-toxic nodular goitre, Sporadic
+∞
11.5
11
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
11.4
1171
9525
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
11.4
1432
11930
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
11.4
3807
34825
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
11.4
475
3356
R03BA02
ATC
budesonide; inhalant
1.3
11.3
1071
8622
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
11.3
1116
9033
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
2.7
11.3
73
268
H02.5
ICD-10 Finland
Other disorders affecting eyelid function
6.0
11.3
30
50
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
11.3
392
2671
E23.05
ICD-10 Finland
Lack of TSH
15.0
11.3
18
12
L01
ICPC
Neck symptom/complaint
1.3
11.3
806
6247
A12BA01
ATC
potassium chloride; oral
1.7
11.3
222
1312
R21
ICPC
Throat symptom/complaint
1.3
11.2
1220
9996
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
4.0
11.2
43
107
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.7
11.2
235
1412
N06AB10
ATC
escitalopram; oral
1.3
11.2
1210
9907
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
11.2
3467
31505
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
2.4
11.1
95
405
N05BA12
ATC
alprazolam; oral
1.4
11.1
583
4297
N06AX21
ATC
duloxetine; oral
1.4
11.1
618
4604
R25.1
ICD-10 Finland
Tremor, unspecified
1.9
11.1
148
767
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.6
11.0
317
2071
J01FF01
ATC
clindamycin; systemic
1.2
11.0
1611
13654
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
10.9
786
6096
G44.2
ICD-10 Finland
Tension-type headache
1.3
10.9
813
6341
R49.08
ICD-10 Finland
Other specified dysphonia
2.1
10.9
125
613
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
10.8
1084
8786
SPAT1254
SPAT
Administration of medicine
1.3
10.8
777
6024
ARB
HP
Catheter ablation of arrhythmia: Cutiing or modification of the AV node
11.9
10.8
19
16
I50
ICD-10 Finland
Heart failure
2.0
10.8
142
734
L03
ICPC
Low back symptom/complaint
1.2
10.8
1461
12270
J01FA06
ATC
roxithromycin; oral
1.2
10.7
2617
23267
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
10.7
2512
22255
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
28.0
10.7
14
5
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
2.8
10.7
67
241
A02BA02
ATC
ranitidine; systemic
1.3
10.7
1101
8960
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
10.6
203
1187
N06AB04
ATC
citalopram; systemic
1.2
10.6
1293
10735
E83.50
ICD-10 Finland
Hypercalcemia
2.6
10.6
73
280
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
1.7
10.6
194
1123
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
10.6
1039
8404
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
10.6
1416
11876
M03BX02
ATC
tizanidine; oral
1.2
10.5
4227
39146
K05
ICPC
Irregular heartbeat other
1.9
10.5
158
857
N03AX12
ATC
gabapentin; oral
1.3
10.5
860
6794
SPAT1260
SPAT
Consultation of another employee
1.3
10.5
1018
8224
A29
ICPC
General symptom/complaint other
1.4
10.5
594
4442
E06.5
ICD-10 Finland
Other chronic thyroiditis
110.1
10.4
11
*
WZC30
NOMESCO Finland
Teaching
1.3
10.4
701
5385
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.6
10.4
232
1423
R4110
NOMESCO Finland
Physiotherapy
1.2
10.3
1586
13491
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.4
10.3
476
3436
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
10.3
807
6336
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
3.2
10.2
52
164
7AX01
NOMESCO Finland
NA
23.4
10.2
14
6
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.4
10.2
439
3126
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
10.2
378
2613
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
7.4
10.1
23
31
N06AB03
ATC
fluoxetine; oral
1.3
10.1
722
5594
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
7.9
10.1
22
28
J01FA09
ATC
clarithromycin; systemic
1.2
10.1
2019
17618
A98
ICPC
Health maint/preventive medicine
1.3
10.0
7371
72004
107
Kela drug reimbursment
Pernicious anaemia
2.3
10.0
93
414
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.4
10.0
505
3700
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.4
10.0
445
3186
A02BC03
ATC
lansoprazole; oral
1.2
10.0
1720
14792
I48.2
ICD-10 Finland
Chronic atrial fibrillation
2.1
10.0
111
538
WX320
NOMESCO Finland
Spinalanesthesy
1.2
9.9
1324
11093
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
9.9
738
5754
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
9.8
388
2718
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.9
9.8
138
733
Z01.2
ICD-10 Finland
Dental examination
1.2
9.8
2621
23444
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.4
9.8
457
3302
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
9.8
985
7990
C09CA01
ATC
losartan; oral
1.2
9.7
1268
10592
N05AH04
ATC
quetiapine; oral
1.3
9.7
875
6997
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.3
9.7
752
5896
4CJ01
NOMESCO Finland
NA
55.0
9.6
11
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
9.6
684
5296
H02AB04
ATC
methylprednisolone; systemic
1.3
9.6
850
6785
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
9.5
2474
22060
SPAT1310
SPAT
Counselling related to known health issue
1.2
9.4
1922
16779
R96
ICPC
Asthma
1.4
9.4
470
3439
A99
ICPC
Disease/condition unspecnature/site
1.4
9.4
414
2961
W84
ICPC
Pregnancy high risk
1.7
9.4
171
987
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
9.4
333
2282
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
2.1
9.4
100
476
E03.3
ICD-10 Finland
Postinfectious hypothyroidism
100.1
9.4
10
*
BA1AE
SPAT
NA
3.1
9.4
48
153
TBA20
NOMESCO Finland
Aspiration cytology of thyroid gland
+∞
9.4
9
*
E03.1
ICD-10 Finland
Congenital hypothyroidism without goitre
+∞
9.4
9
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
9.4
9
*
J01MA12
ATC
levofloxacin; systemic
1.3
9.4
963
7829
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
9.2
329
2257
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.3
9.2
698
5449
UKC02
NOMESCO Finland
Cystoscopy
1.3
9.2
699
5463
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
5.0
9.2
28
56
N05CF02
ATC
zolpidem; oral
1.2
9.2
1040
8548
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.4
9.2
466
3419
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
1.7
9.2
174
1019
R03BA05
ATC
fluticasone; inhalant
1.2
9.2
1071
8839
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
2.1
9.2
98
469
C08DB01
ATC
diltiazem; oral
1.6
9.1
245
1579
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
9.1
505
3761
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
3.1
9.1
47
151
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.4
9.1
405
2904
I49.1
ICD-10 Finland
Atrial premature depolarization
1.7
9.1
177
1046
L17
ICPC
Foot/toe symptom/complaint
1.2
9.1
1450
12367
24210
ICD-8 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre
8.3
9.0
19
23
A08
ICPC
Swelling
1.6
9.0
216
1350
Z32.1
ICD-10 Finland
Pregnancy confirmed
1.4
9.0
515
3859
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
18.6
8.9
13
7
N02AA05
ATC
oxycodone; systemic
1.3
8.9
706
5548
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.4
8.9
71
294
R52.9
ICD-10 Finland
Pain, unspecified
1.4
8.9
449
3295
XF640
NOMESCO Finland
NA
1.8
8.8
141
782
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.6
8.8
206
1281
D01
ICPC
Abdominal pain/cramps general
1.3
8.8
607
4681
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
1.6
8.8
194
1189
C01DA14
ATC
isosorbide mononitrate; oral
1.3
8.7
626
4853
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
8.7
4347
40655
TFP52
NOMESCO Finland
Ablation treatment of ventricular tachycardia due to structural heart defect
14.0
8.7
14
10
M03BC01
ATC
orphenadrine (citrate); systemic
1.2
8.6
1426
12198
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
7.6
8.6
19
25
R01AD12
ATC
fluticasone furoate; nasal
1.2
8.6
1868
16376
C07AB03
ATC
atenolol; systemic
1.5
8.6
283
1910
ZX114
NOMESCO Finland
Intramuscular
2.3
8.6
75
325
-34
ICPC
Blood test
1.8
8.6
151
867
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.5
8.6
259
1716
R07.3
ICD-10 Finland
Other chest pain
1.4
8.6
489
3660
WZA90
NOMESCO Finland
Other doctors statement
1.2
8.6
1332
11319
L15
ICPC
Knee symptom/complaint
1.2
8.6
1191
10010
R05
ICPC
Cough
1.2
8.5
1326
11272
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
2.6
8.5
58
220
FPE96
NOMESCO Finland
Other implantation or replacement of transvenous cardiac pacemaker
3.8
8.5
34
90
H03AA02
ATC
liothyronine sodium; systemic
20.0
8.5
12
6
P01AB01
ATC
metronidazole; oral, rectal
1.2
8.4
2613
23582
-60
ICPC
Result test/procedure
1.5
8.4
314
2179
2410A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic uninodular goitre
+∞
8.3
8
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
8.3
521
3959
N17
ICPC
Vertigo/dizziness
1.3
8.3
591
4576
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.6
8.3
199
1246
M02AA07
ATC
piroxicam; topical
1.2
8.3
2224
19838
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
2.4
8.3
65
270
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.3
8.3
661
5201
E04
ICD-10 Finland
Other nontoxic goitre
5.2
8.3
24
46
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
3.0
8.3
45
151
WX722
NOMESCO Finland
PEEP
1.6
8.3
202
1271
R55
ICD-10 Finland
Syncope and collapse
1.3
8.3
511
3876
J20
ICD-10 Finland
Acute bronchitis
1.3
8.2
521
3968
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
2.4
8.2
64
264
FPG40
NOMESCO Finland
Replacement of pulse generator in transvenous cardioverter-defibrillator
6.5
8.2
20
31
AS7
HP
Arrhythmia pacemaker insertion VVI (R) S
6.5
8.2
20
31
SPAT1283
SPAT
Restricted health certificate
1.2
8.2
1069
8925
C03AA03
ATC
hydrochlorothiazide; oral
1.3
8.1
483
3638
T90
ICPC
Diabetes non-insulin dependent
1.2
8.1
1086
9088
205
Kela drug reimbursment
Chronic hypertension
1.2
8.1
1365
11688
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.8
8.1
130
726
S18
ICPC
Laceration/cut
1.2
8.1
2425
21804
XF602
NOMESCO Finland
Bloodpressure monitoring
2.6
8.1
56
216
J01CE02
ATC
phenoxymethylpenicillin; oral
1.1
8.1
4702
44339
WX902
NOMESCO Finland
External defibrillation of heart
4.7
8.1
26
56
F29
ICPC
Eye symptom/complaint other
1.4
8.1
436
3238
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.4
8.1
441
3280
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
6.8
8.0
19
28
G04BE03
ATC
sildenafil; oral
2.7
8.0
52
194
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.9
8.0
117
631
FXE00
NOMESCO Finland
Use of ECLA
22.0
8.0
11
5
E66.8
ICD-10 Finland
Other obesity
1.5
8.0
270
1836
SPAT1153
SPAT
Removal of sutures
1.2
8.0
1806
15881
D11
ICPC
Diarrhoea
1.3
8.0
609
4767
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
7.9
952
7871
-50
ICPC
Medication/prescr/renewal
1.6
7.9
208
1333
SPAT1104
SPAT
Monitoring of emergency patient
1.4
7.9
329
2329
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
7.9
495
3763
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
7.9
1934
17121
M79.1
ICD-10 Finland
Myalgia
1.3
7.8
735
5906
FM1CD
NOMESCO Finland
Very extensive CT of heart
4.5
7.8
26
58
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
4.0
7.8
29
72
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
1.8
7.8
121
667
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.3
7.8
636
5018
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
1.8
7.8
121
669
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.4
7.8
382
2793
J02AC01
ATC
fluconazole; systemic
1.1
7.8
2874
26235
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.4
7.7
331
2360
C10AA05
ATC
atorvastatin; oral
1.2
7.7
1934
17133
M01AB05
ATC
diclofenac; systemic, rectal
1.1
7.7
4472
42088
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.8
7.7
47
171
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
7.7
2277
20445
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.5
7.7
230
1526
R35
ICD-10 Finland
Polyuria
1.5
7.6
267
1830
WX882
NOMESCO Finland
High dependency care
1.8
7.6
124
697
UJF30
NOMESCO Finland
Ileoscopy through colon
1.3
7.6
497
3803
A60
ICPC
General and Unspecified, Result test/procedure
1.5
7.6
228
1510
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
7.6
615
4851
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
25.0
7.6
10
*
FPJ21
NOMESCO Finland
Revision of cardioverter-defibrillator with ventricular electrode
8.8
7.5
15
17
105
Kela drug reimbursment
Adrenal cortical hypofunction
5.7
7.5
20
35
SPAT1216
SPAT
Assessment of functional ability
1.3
7.5
774
6294
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
2.8
7.5
45
162
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.4
7.5
368
2689
N07BA03
ATC
varenicline; oral
1.5
7.4
260
1781
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.3
7.4
481
3675
H50.52
ICD-10 Finland
Exophoria
2.3
7.4
62
266
SPAT1229
SPAT
Assessment of need for aid
1.4
7.4
381
2803
C10AA07
ATC
rosuvastatin; oral
1.2
7.4
1214
10358
N05BA01
ATC
diazepam; systemic, rectal
1.3
7.4
704
5666
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
1.7
7.4
138
806
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
2.4
7.4
60
255
E03.4
ICD-10 Finland
Atrophy of thyroid (acquired)
80.2
7.4
8
*
8340/3-C73.9
ICD-O-3
Papillary carcinoma, follicular variant of thyroid gland
80.2
7.4
8
*
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
80.2
7.4
8
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.4
7.4
294
2069
R03DC03
ATC
montelukast; oral
1.2
7.4
943
7852
CE2W4
NOMESCO Finland
Eye movement mapping
5.3
7.4
21
40
R52.2
ICD-10 Finland
Other chronic pain
1.6
7.3
168
1043
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
7.3
1961
17461
SPAT1379
SPAT
Health check-up of pregnant person
1.3
7.3
537
4178
2448A
ICD-9 Finland
Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS POST THYREOIDITIDEM]
+∞
7.3
7
*
2449X
ICD-9 Finland
Acquired hypothyroidism, Unspecified hypothyroidism
+∞
7.3
7
*
C10AX09
ATC
ezetimibe; oral
1.3
7.3
477
3654
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.7
7.3
135
792
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.7
7.3
154
938
J01MA02
ATC
ciprofloxacin; systemic
1.2
7.2
2223
19998
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
2.1
7.2
77
372
T71
ICPC
Malignant neoplasm thyroid
30.0
7.1
9
*
TFP32
NOMESCO Finland
Cathetric treatmen of cardiac arrythmia
2.8
7.1
42
149
I44.2
ICD-10 Finland
Atrioventricular block, complete
1.9
7.1
104
565
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.3
7.1
65
290
R60.9
ICD-10 Finland
Oedema, unspecified
1.5
7.1
231
1562
RD210
NOMESCO Finland
NA
1.9
7.1
91
470
TFP45
NOMESCO Finland
Ablation treatment of non-typical atrial flutter
7.9
7.1
15
19
C09AA02
ATC
enalapril; systemic
1.2
7.1
949
7942
CKC12
NOMESCO Finland
Photocoagulation of retina
1.5
7.1
194
1263
A10BA02
ATC
metformin; oral
1.2
7.0
1336
11556
WX872
NOMESCO Finland
Intensive care
1.5
7.0
206
1361
M79.7
ICD-10 Finland
Fibromyalgia
1.6
7.0
181
1159
JN4AD
NOMESCO Finland
Body CT examination
1.4
7.0
348
2547
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
2.8
7.0
42
151
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.3
7.0
634
5079
FPB22
NOMESCO Finland
Transvenous radiofrequency ablation of aberrant pathway or focus of heart
4.9
6.9
21
43
D09
ICPC
Nausea
1.5
6.9
211
1406
E21.0
ICD-10 Finland
Primary hyperparathyroidism
2.0
6.9
77
378
A12AA04
ATC
calcium carbonate; oral
2.1
6.9
69
323
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.8
6.9
115
653
SPAT1240
SPAT
Therapeutic discussion
1.3
6.9
584
4635
R5140
NOMESCO Finland
Monitoring the use of the aid
1.3
6.9
461
3543
M04AA01
ATC
allopurinol; systemic
1.3
6.9
494
3834
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.3
6.9
58
251
I41.8*D86.8
ICD-10 Finland
Sarcoid myocarditis
4.0
6.9
25
62
B01AE07
ATC
dabigatran etexilate; oral
1.6
6.8
168
1065
L02
ICPC
Back symptom/complaint
1.3
6.8
486
3769
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.3
6.8
469
3620
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.4
6.8
276
1954
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.2
6.8
61
274
XKD00
NOMESCO Finland
Uroflowmetry
1.3
6.8
520
4075
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
6.8
1650
14573
BAA99
NOMESCO Finland
Other operation on thyroid gland
40.0
6.8
8
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.3
6.7
427
3255
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
2.3
6.7
60
266
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
1.9
6.7
86
445
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
6.7
353
2613
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.4
6.7
330
2415
R4130
NOMESCO Finland
Speech therapy
1.8
6.7
100
548
2506
FHL
Thyroidectomy
22.5
6.7
9
*
A09
ICPC
Sweating problem
2.2
6.7
60
269
K04.0
ICD-10 Finland
Pulpitis
1.3
6.7
502
3923
A13
ICPC
Concern/fear medical treatment
2.0
6.7
81
410
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.1
6.6
70
337
R03AK08
ATC
formoterol and beclometasone; inhalant
1.5
6.6
189
1242
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
7.8
6.6
14
18
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
6.6
213
1440
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
12.2
6.6
11
9
A03
ICPC
Fever
1.2
6.5
875
7320
SPAT1281
SPAT
Other administrative function
1.3
6.5
402
3052
CS494
NOMESCO Finland
Other visual field testing
1.8
6.5
106
600
R49.01
ICD-10 Finland
Functional dysphonia
1.6
6.5
146
906
M01AE02
ATC
naproxen; oral, rectal
1.1
6.5
3739
35009
L08
ICPC
Shoulder symptom/complaint
1.2
6.4
1009
8574
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
2.1
6.4
69
336
2441A
ICD-9 Finland
Acquired hypothyroidism, Other postablative hypothyroidism
69.9
6.4
7
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
69.9
6.4
7
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
6.4
843
7037
A28
ICPC
Limited function/disability NOS
1.2
6.4
688
5618
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.3
6.4
595
4779
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
3.3
6.4
29
87
E66.01
ICD-10 Finland
Obesity due to excess calories
1.3
6.4
407
3104
J37.0
ICD-10 Finland
Chronic laryngitis
1.6
6.4
155
978
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.3
6.4
501
3938
I25.2
ICD-10 Finland
Old myocardial infarction
1.5
6.4
235
1629
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
4.7
6.4
20
43
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.4
6.4
259
1833
ZXA05
NOMESCO Finland
Left side
1.2
6.4
1404
12294
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.5
6.4
177
1159
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.4
6.4
346
2577
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.5
6.3
186
1232
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
6.3
636
5152
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
2.5
6.3
46
186
R31
ICD-10 Finland
Unspecified haematuria
1.3
6.3
376
2839
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.4
6.3
247
1738
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
2.2
6.3
60
277
E50.9
ICD-10 Finland
Vitamin A deficiency, unspecified
9.2
6.3
12
13
FPD00
NOMESCO Finland
Maze procedure for atrial fibrillation
9.2
6.3
12
13
A91
ICPC
Abnormal result investigation NOS
1.5
6.3
200
1348
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
6.3
542
4315
I43.8*E05.9
ICD-10 Finland
Thyrotoxic heart disease
+∞
6.2
6
*
BA1MN
NOMESCO Finland
Thyroid gland isotope imaging with calculation
+∞
6.2
6
*
E8901, E050
ICD-10 Finland
NA
+∞
6.2
6
*
O992, E050
ICD-10 Finland
NA
+∞
6.2
6
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.3
6.2
355
2664
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.5
6.2
195
1309
2422A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic multinodular goitre
26.7
6.2
8
*
P74
ICPC
Anxiety disorder/anxiety state
1.5
6.2
180
1190
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
6.2
1446
12713
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
2.5
6.2
45
182
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.2
6.2
1103
9482
ZXA00
NOMESCO Finland
Right side
1.2
6.2
1505
13276
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
2.5
6.2
44
174
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.2
6.2
676
5535
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.4
6.2
318
2350
FM1JR
NOMESCO Finland
Heart, extensive metabolic PET with CT
5.0
6.2
18
36
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.3
6.2
509
4028
3A064
NOMESCO Finland
NA
3.8
6.1
24
64
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.2
6.1
1123
9674
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
1.8
6.1
99
557
T72
ICPC
Benign neoplasm thyroid
5.7
6.1
16
28
L84
ICD-10 Finland
Corns and callosities
1.6
6.1
154
985
K60
ICPC
Cardiovascular, Result test/procedure
2.6
6.1
41
159
K30
ICD-10 Finland
Functional dyspepsia
1.3
6.1
572
4597
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
1.8
6.1
97
543
E23.00
ICD-10 Finland
Panhypopituitarism
7.7
6.1
13
17
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.5
6.1
168
1098
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.6
6.1
152
968
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.5
6.1
204
1391
P03
ICPC
Feeling depressed
1.3
6.1
473
3715
D05.0
ICD-10 Finland
Lobular carcinoma in situ
4.2
6.1
21
50
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.2
6.1
674
5524
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
1.9
6.1
83
441
M01AB55
ATC
diclofenac, combinations; oral
1.3
6.1
351
2640
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
2.5
6.1
44
178
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.5
6.1
172
1132
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.4
6.0
226
1576
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.5
6.0
210
1443
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.4
6.0
233
1636
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
194
51
38.86
316.89
4.5
1.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1374
4719
3.26
310.37
3.3
3.6
ng/l
66.4
89.8
19.06
1216
4037
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
300
238
13.01
310.03
3.5
1.3
u/ml
130.5
145.0
0.08
94
39
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
8584
68144
6.80
307.65
15.0
3.4
mu/l
1.7
2.0
6.26
8268
62573
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
8487
56439
10.07
307.65
13.8
2.6
pmol/l
15.6
14.4
313.55
8188
51241
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
2685
3961
9.24
307.65
1.4
1.1
iu/ml
201.4
85.5
24.81
1264
1320
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
5362
34382
2.39
307.65
7.7
6.0
mmol/l
1.2
1.2
0.45
4515
28963
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
4419
856
100.61
307.65
2.8
1.2
iu/l
20.5
2.6
1.24
2370
185
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5087
2541
44.83
307.65
7.1
1.7
pmol/l
4.8
4.5
22.00
4741
2234
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4898
31048
2.27
306.74
6.7
5.4
mmol/l
1.2
1.2
0.30
4526
28045
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
237
135
18.00
292.91
1.7
1.2
pmol/l
17.7
13.7
4.54
211
116
(3013650) Neutrophils [#/volume] in Blood by Automated count
5993
42143
2.27
279.68
9.6
8.9
e9/l
3.9
4.0
7.66
5209
36763
(3018418) pH of Serum or Plasma
3510
20559
2.16
253.60
4.8
3.7
ph
7.4
7.4
0.15
686
3838
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
7061
55712
2.25
211.82
8.9
7.2
u/l
78.6
77.2
2.03
6745
52385
(3015377) Calcium [Moles/volume] in Serum or Plasma
3768
24006
1.98
204.73
3.0
3.3
mmol/l
2.3
2.4
12.24
3344
20918
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4407
30930
1.83
166.54
2.6
2.2
nmol/l
76.2
3005.2
0.50
4002
28008
(3013707) Erythrocyte sedimentation rate by Westergren method
6778
54751
1.97
160.09
4.4
4.0
mm/h
11.9
11.9
0.10
6331
50848
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1268
6154
2.23
135.99
2.2
2.0
nmol/l
378.1
378.2
0.00
1158
5647
(3001019) Free T4 and TSH panel - Serum or Plasma
896
3768
2.53
132.93
2.3
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
506
1569
3.36
131.35
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
2848
18558
1.78
128.81
7.5
6.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
4943
37526
1.71
128.40
6.2
6.0
e9/l
0.2
0.2
0.06
4363
32960
(3022096) Basophils/100 leukocytes in Blood
4434
32823
1.69
125.43
6.1
6.0
%
0.7
0.7
2.84
4116
30554
(3002030) Lymphocytes/100 leukocytes in Blood
4672
35095
1.69
124.82
6.1
6.0
%
28.1
28.4
0.88
4335
32694
(3019069) Monocytes/100 leukocytes in Blood
4560
34097
1.68
123.42
6.3
6.2
%
8.5
8.4
2.34
4246
31923
(3006504) Eosinophils/100 leukocytes in Blood
4536
33920
1.68
122.31
6.1
5.9
%
2.8
2.8
0.03
4212
31559
(3006315) Basophils [#/volume] in Blood
4782
36294
1.68
121.52
5.9
5.8
e9/l
0.0
0.0
5.93
4131
31326
(3019198) Lymphocytes [#/volume] in Blood
4878
37266
1.68
120.43
5.9
5.8
e9/l
1.9
1.9
1.02
4303
32800
(3001604) Monocytes [#/volume] in Blood
4760
36141
1.67
120.27
5.9
5.7
e9/l
0.6
0.6
0.25
4119
31201
(3018010) Neutrophils/100 leukocytes in Blood
4584
34631
1.66
116.67
5.9
5.8
%
57.0
57.1
0.17
4267
32376
(3019550) Sodium [Moles/volume] in Serum or Plasma
8357
75437
2.54
113.87
19.3
14.1
mmol/l
139.7
139.7
0.19
8193
73461
(3023103) Potassium [Moles/volume] in Serum or Plasma
8369
75655
2.55
112.57
19.6
14.2
mmol/l
3.9
3.9
0.22
8189
73512
(42870588) Differential panel, method unspecified - Blood
3436
24289
1.67
111.74
5.7
5.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2543
16947
1.70
101.17
1.4
1.3
u/ml
1.8
1.7
0.25
663
4542
(3013826) Glucose [Moles/volume] in Serum or Plasma
5139
41065
1.59
95.39
5.2
4.3
mmol/l
6.6
6.6
1.54
4824
38030
(3044889) 12 lead EKG panel
6019
49964
1.62
94.85
4.5
3.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
4206
32183
1.58
93.44
11.1
8.9
e9/l
0.0
0.0
0.05
3479
26154
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2619
17941
1.65
92.03
4.2
2.8
ng/l
1382.3
1258.4
0.93
2255
15304
(3001122) Ferritin [Mass/volume] in Serum or Plasma
4301
33222
1.57
90.67
3.3
2.7
ug/l
103.4
106.3
0.43
3994
30954
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1750
10836
1.76
89.06
4.0
3.3
mmol/l
0.8
0.8
2.13
1622
10107
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7748
69316
1.85
86.51
15.7
11.7
ml/min/173m2
83.3
83.1
0.30
6636
56710
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
8522
79120
2.49
82.58
13.5
9.7
u/l
24.3
25.0
3.69
8336
76347
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1382
8147
1.82
82.39
5.3
5.4
mmol/l
1.0
1.0
0.36
1263
7603
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
8173
74679
2.04
81.79
16.6
12.8
mg/l
20.6
22.5
6.17
6668
58202
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3703
28227
1.53
79.13
2.1
1.9
pmol/l
96.1
97.0
0.55
1968
14190
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
358
1226
3.00
78.22
2.3
2.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
7418
66023
1.71
77.81
6.1
5.1
mmol/mol
39.8
39.0
11.53
6888
61251
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4607
37025
1.50
75.00
6.3
5.9
umol/l
11.0
10.8
0.56
4363
35048
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3375
25452
1.52
74.49
4.1
3.3
ng/l
42.5
64.8
0.56
2134
15934
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2465
17350
1.58
74.29
2.5
2.2
mg/l
2.9
2.9
0.09
2145
14839
(3024561) Albumin [Mass/volume] in Serum or Plasma
3896
30326
1.50
73.62
4.6
4.5
g/l
35.6
35.7
1.04
3599
28136
(3007164) IgA [Mass/volume] in Serum or Plasma
2142
14616
1.61
73.48
1.5
1.4
g/l
2.2
2.3
2.25
1254
8835
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1526
9602
1.71
71.61
2.6
2.3
g/l
2.4
2.4
1.77
1396
8884
(3022948) Iron [Moles/volume] in Serum or Plasma
1626
10462
1.68
70.02
2.6
2.3
umol/l
13.4
13.1
0.69
1491
9690
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
7801
71121
1.73
66.01
4.7
4.2
mmol/l
5.9
5.8
7.28
7149
65167
(3032080) INR in Blood by Coagulation assay
3474
26835
1.48
65.81
12.3
8.0
inr
1.3
1.2
5.73
1080
7744
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1406
8914
1.68
63.41
2.7
2.4
%
22.1
22.5
0.42
1206
7622
(3044640) Blood type and Crossmatch panel - Blood
3068
23298
1.48
62.44
2.4
2.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
8347
78169
1.95
57.73
17.6
11.8
—
—
—
0
0
(3013512) EKG study
2621
19574
1.48
56.77
4.4
3.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
947
5575
1.78
55.22
4.0
3.5
mmol/l
1.2
1.2
5.00
843
4852
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2872
22135
1.44
51.60
2.7
2.4
u/l
57.5
58.2
0.22
2631
20406
(3027456) Digoxin [Moles/volume] in Serum or Plasma
296
1158
2.61
50.20
3.4
3.1
nmol/l
0.9
0.8
0.44
232
883
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2349
17576
1.46
48.92
2.3
2.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2643
20380
1.42
46.18
2.2
2.1
u/l
200.1
201.1
0.01
2490
19121
(3019225) pH of Specimen
1060
6743
1.65
46.08
5.0
3.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2189
16320
1.45
45.95
2.7
1.7
mg/l
1.0
1.1
0.89
1642
12407
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1790
12876
1.49
45.04
2.9
2.9
mmol/l
2.4
2.5
1.60
1517
11242
(3019309) Folate [Moles/volume] in Red Blood Cells
1705
12198
1.49
43.94
1.8
1.7
nmol/l
1090.7
1182.5
4.42
1328
9197
(3022217) INR in Platelet poor plasma by Coagulation assay
1239
8298
1.57
43.33
30.3
22.4
inr
1.4
1.3
1.79
166
1216
(3002385) Erythrocyte distribution width [Ratio]
6898
62711
1.43
42.62
22.8
15.4
%
13.7
13.6
0.46
6788
61406
(3026782) Osmolality of Urine
1829
13340
1.47
42.58
3.0
2.7
mosm/kgh2o
522.1
532.6
1.25
1544
11264
(3007461) Platelets [#/volume] in Blood
8688
83466
2.23
41.67
28.1
18.7
e9/l
258.5
258.6
0.09
8555
81358
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1800
13140
1.46
41.59
4.4
3.4
ng/l
283.6
450.5
0.74
1367
9554
(3035941) MCH [Entitic mass]
8690
83512
2.23
41.32
28.0
18.6
pg
30.1
30.2
11.62
8620
82376
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
4159
34985
1.35
41.24
4.0
3.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5609
49383
1.36
41.20
3.3
2.9
u/l
43.7
43.5
0.06
5270
46233
(3026361) Erythrocytes [#/volume] in Blood
8690
83525
2.23
41.09
28.1
18.7
e12/l
4.5
4.5
19.14
8528
81216
(3024731) MCV [Entitic volume]
8689
83519
2.22
40.95
28.0
18.6
fl
90.6
90.9
6.44
8620
82386
(3010813) Leukocytes [#/volume] in Blood
8690
83544
2.22
40.74
28.2
18.7
e9/l
6.6
6.7
0.57
8529
81201
(3000963) Hemoglobin [Mass/volume] in Blood
8690
83549
2.22
40.65
28.3
18.8
g/l
134.5
133.8
5.43
8622
82421
(3037467) Urinalysis macro (dipstick) panel - Urine
5786
51276
1.36
40.19
4.9
4.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
946
6177
1.59
36.50
1.2
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
5581
49573
1.33
35.79
5.1
4.3
e6/l
1508.6
2220.0
0.47
71
607
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7881
74114
1.52
35.38
5.0
4.5
mmol/l
2.8
2.8
9.59
7275
68458
(3033658) Prothrombin time (PT) actual/Normal
2319
18162
1.37
34.93
4.5
3.7
%
88.9
93.0
11.02
2264
17707
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1064
7217
1.54
34.62
5.5
4.1
u/l
236.8
243.6
0.78
1006
6784
(40760892) CBC W Ordered Manual Differential panel - Blood
2104
16250
1.38
34.45
4.1
4.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
190
727
2.65
33.77
1.6
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1433
10375
1.45
33.77
1.4
1.3
titre
460.8
534.4
0.96
327
2180
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7758
72853
1.47
33.74
4.6
4.1
mmol/l
4.7
4.8
23.66
7205
67703
(3021960) Folate [Moles/volume] in Serum or Plasma
2027
15636
1.38
33.25
1.6
1.5
nmol/l
19.8
21.0
3.44
1754
13329
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1454
10595
1.44
33.04
1.9
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2917
23822
1.33
32.96
3.3
3.1
u/l
29.3
33.8
3.62
2772
22619
(3027945) Reticulocytes/100 erythrocytes in Blood
1026
6987
1.53
32.67
2.4
2.5
%
1.7
1.8
0.94
907
6200
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
7456
69671
1.41
31.73
4.0
3.6
mmol/l
1.3
1.2
0.24
6846
64106
(3002582) Erythrocytes [#/volume] in Urine
2601
21053
1.33
30.76
3.5
3.0
e6/l
86.7
69.8
0.21
1995
15797
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
825
5427
1.57
30.60
4.2
2.7
ng/l
243.8
179.0
2.59
755
4935
(3021447) Carbon dioxide [Partial pressure] in Venous blood
855
5676
1.56
30.46
3.7
3.8
kpa
5.9
5.8
0.34
816
5510
(3030467) Casts [#/volume] in Urine by Automated count
2413
19351
1.34
30.32
3.4
3.0
e6/l
0.4
0.4
0.18
1819
14296
(3002032) Base excess in Venous blood by calculation
853
5668
1.56
30.26
3.7
3.8
mmol/l
1.9
2.0
0.12
693
4636
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
7687
72356
1.43
30.15
4.5
4.0
mmol/l
1.5
1.5
20.98
7099
66980
(3020630) Protein [Mass/volume] in Serum or Plasma
788
5184
1.57
29.17
2.4
2.6
g/l
65.5
66.6
3.96
717
4710
(40768797) Stomach Pathology biopsy report
1344
9874
1.42
28.83
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2222
17732
1.34
28.55
4.5
4.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2358
19008
1.33
28.19
3.4
2.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
2493
20291
1.32
27.74
3.3
3.1
mmol/l
7.1
7.2
0.29
2062
17079
(3020682) Albumin/Creatinine [Ratio] in Urine
2410
19527
1.32
27.69
4.3
3.8
mg/mmol
9.2
8.9
0.09
1476
11841
(3018095) Leukocytes [#/volume] in Urine
3029
25353
1.29
27.24
4.1
3.5
e6/l
87.7
104.1
0.79
2149
17198
(3020779) Urea [Moles/volume] in Serum or Plasma
795
5328
1.54
27.02
10.4
7.0
mmol/l
9.6
9.1
0.94
758
5085
(3012516) Albumin [Mass/volume] in Urine
2300
18589
1.32
26.72
3.5
3.1
mg/l
507.4
387.0
0.52
1466
11189
(40768804) Tissue Pathology biopsy report
3655
31383
1.28
26.71
2.1
2.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1840
14474
1.34
25.63
2.7
2.5
e6/l
6.9
6.8
0.16
1585
12563
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1825
14444
1.33
24.19
1.7
1.6
pmol/l
41508631.8
34647676.1
0.19
1525
12076
(3009542) Hematocrit [Volume Fraction] of Blood
7334
69079
1.34
23.79
20.5
13.7
%
39.8
39.4
3.19
5428
51537
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
70
183
3.85
23.62
1.3
1.6
ug/l
0.4
0.4
0.49
33
126
(3000991) Gas panel - Venous blood
767
5246
1.51
23.60
9.2
7.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1117
8208
1.41
23.58
2.7
2.6
umol/l
8.1
7.8
0.16
962
7000
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
484
2991
1.65
23.12
3.9
4.2
mmol/l
24.3
24.3
0.19
455
2690
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1723
13605
1.33
23.07
1.3
1.3
iu/ml
28.1
33.3
0.87
509
4358
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1427
10978
1.36
22.72
3.2
2.7
e6/l
3.9
3.4
0.70
784
5698
(3026493) Urate [Moles/volume] in Serum or Plasma
2179
17817
1.29
22.53
2.6
2.4
umol/l
3881.4
4243.5
0.16
1861
15500
(3020961) Endomysium IgA Ab [Titer] in Serum
557
3590
1.59
22.41
1.2
1.1
titre
119.8
231.9
1.29
23
87
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
590
3857
1.57
22.32
8.6
6.8
mmol/l
25.0
24.8
0.57
590
3831
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
227
1138
2.02
21.56
1.2
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
790
5536
1.47
21.49
8.1
6.6
mmol/l
1.2
1.3
1.44
756
5352
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
109
398
2.76
21.38
2.1
1.9
nmol/l
18.3
19.6
0.76
99
376
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
949
6903
1.42
21.11
3.4
3.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2725
23067
1.26
20.96
3.4
3.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
97
338
2.89
20.76
1.7
1.5
mmol/24h
3.1
5.8
—
6
23
(3024354) Oxygen [Partial pressure] in Venous blood
680
4683
1.49
20.16
3.4
3.1
kpa
4.5
4.6
0.30
644
4531
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1617
12889
1.31
19.89
1.3
1.3
u/ml
7.0
12.0
2.80
586
5139
(3021601) Nitrite [Presence] in Urine by Test strip
4120
36716
1.23
19.24
5.3
4.8
estimate
0.0
0.0
2.09
859
6766
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
971
7218
1.39
18.94
1.8
1.7
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
164
767
2.16
18.78
1.2
1.2
u/l
77.8
63.4
0.91
109
520
(3000492) Spirometry study
940
6962
1.39
18.73
1.5
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
967
7196
1.39
18.73
1.8
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
620
4254
1.49
18.70
2.1
2.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
369
2248
1.67
18.65
1.5
1.6
titre
182.7
335.2
0.83
15
99
(3052851) Hemolysis interference index of Serum or Plasma
352
2120
1.69
18.58
3.3
3.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
501
3290
1.55
18.57
10.3
8.8
mmol/l
24.5
24.3
0.82
471
3081
(3035350) Ketones [Presence] in Urine by Test strip
4092
36524
1.22
18.55
3.9
3.6
estimate
0.0
0.0
1.08
834
6624
(40761536) Microorganisms panel - Urine sediment
851
6207
1.41
18.54
3.9
3.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1058
8015
1.36
18.32
7.9
6.7
mmol/l
104.5
104.4
0.30
1040
7842
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2256
18956
1.25
17.93
1.7
1.6
mmol/l
1.3
1.3
0.00
1857
16070
(3009261) Glucose [Presence] in Urine by Test strip
4139
37065
1.22
17.91
4.0
3.6
estimate
0.0
0.0
0.04
833
6677
(3023520) Reticulocytes [#/volume] in Blood
723
5158
1.44
17.81
2.4
2.5
e9/l
72.8
70.2
0.99
537
3821
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
331
1992
1.69
17.53
4.7
3.3
u/ml
0.3
0.4
0.14
197
1123
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
528
3563
1.51
17.26
3.6
3.4
mmol/l
1.9
1.8
0.15
387
2642
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
438
2839
1.57
17.20
1.8
1.6
g/l
1.5
1.5
0.21
376
2418
(3048689) Calprotectin [Mass/mass] in Stool
1223
9574
1.32
16.90
2.0
2.3
ug/g
123.0
119.0
0.13
934
7483
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
549
3769
1.49
16.51
3.6
3.4
kpa
5.2
5.2
0.42
509
3477
(3009343) pH of Capillary blood
542
3716
1.49
16.40
3.6
3.4
ph
7.4
7.4
0.00
70
502
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
98
389
2.54
16.39
1.1
1.1
nmol/l
7.4
8.5
0.06
19
76
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
87
326
2.69
16.34
13.1
12.0
mmol/l
0.6
0.6
0.79
79
296
(3009445) Proteinase 3 Ab [Units/volume] in Serum
436
2861
1.55
16.22
1.4
1.6
u/ml
13.4
15.8
—
8
86
(3005719) IgG [Mass/volume] in Serum or Plasma
729
5300
1.41
16.13
2.3
2.7
g/l
10.1
10.4
1.11
657
4868
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1274
10093
1.31
16.09
3.0
2.1
s
30.5
29.6
4.95
1234
9774
(3041096) Erythrocytes [Presence] in Urine by Automated
2329
19848
1.23
15.93
3.7
3.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
553
3844
1.47
15.61
1.7
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
590
4154
1.45
15.58
1.7
1.9
g/l
1.2
1.4
2.07
539
3807
(3021387) Prolactin [Units/volume] in Serum or Plasma
408
2663
1.56
15.56
1.6
1.5
mu/l
302.0
300.5
0.03
358
2405
(3027801) Oxygen [Partial pressure] in Arterial blood
949
7243
1.35
15.54
7.7
6.8
kpa
12.2
12.7
2.19
905
6913
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
949
7244
1.35
15.52
7.7
6.8
kpa
5.1
5.1
0.35
908
6915
(3003396) Base excess in Arterial blood by calculation
947
7243
1.34
15.28
7.7
6.8
mmol/l
1.1
1.1
0.03
740
5685
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
465
3138
1.51
15.21
1.1
1.1
u/ml
1.6
1.8
—
10
45
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
190
1014
1.89
15.17
1.2
1.3
nmol/l
0.6
1.7
0.50
179
976
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
690
5024
1.40
15.12
1.6
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
855
6449
1.36
15.11
2.3
2.1
g/l
0.2
0.2
0.15
801
6034
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
342
2159
1.61
15.05
1.1
1.1
u/ml
3.8
6.4
0.74
43
276
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
190
1017
1.89
15.03
1.2
1.3
nmol/l
0.2
0.3
—
8
72
(3017181) Myelocytes/100 leukocytes in Blood
782
5820
1.38
15.03
3.9
4.1
%
1.1
0.9
0.64
203
1570
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1463
11901
1.27
14.94
3.0
2.6
e6/l
1.1
1.5
0.77
813
6576
(3003694) ABO and Rh group [Type] in Blood
2455
21154
1.22
14.90
1.5
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
533
3717
1.46
14.80
3.5
3.2
g/l
132.0
128.0
4.19
514
3633
(3021440) Promyelocytes/100 leukocytes in Blood
751
5568
1.38
14.77
3.9
4.1
%
0.1
0.2
1.30
190
1465
(3024928) Oxygen saturation in Venous blood
231
1321
1.77
14.75
3.2
3.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
442
2975
1.51
14.64
2.2
2.0
u/l
39.0
39.3
0.09
391
2651
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
360
2319
1.58
14.56
3.8
3.8
mmol/l
24.9
24.9
0.11
331
2134
(3025159) Blasts/100 leukocytes in Blood
712
5246
1.39
14.54
3.8
4.2
%
0.0
0.3
1.70
163
1232
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
297
1830
1.64
14.43
1.9
2.3
g/l
0.0
0.0
0.95
274
1679
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
355
2288
1.57
14.33
1.9
2.3
g/l
3.1
3.1
0.06
282
1788
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
328
2077
1.60
14.27
2.1
2.4
g/l
0.5
0.8
1.17
288
1795
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
293
1807
1.64
14.19
1.3
1.4
iu/ml
7.5
12.5
—
5
41
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
417
2795
1.52
14.10
2.0
1.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
306
1911
1.62
14.10
1.9
2.2
g/l
37.5
37.9
0.76
271
1643
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
370
2419
1.55
14.03
2.0
2.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
279
1708
1.65
13.92
1.9
2.3
g/l
0.0
0.0
0.77
257
1561
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
370
2425
1.55
13.88
2.0
2.3
g/l
7.5
7.4
0.14
285
1833
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
276
1687
1.66
13.85
1.9
2.3
g/l
0.0
0.0
0.00
257
1557
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
369
2421
1.55
13.78
2.0
2.3
g/l
3.8
3.8
0.00
278
1735
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
878
6762
1.33
13.46
2.6
2.4
u/l
41.8
44.9
0.15
764
5782
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
13
10
13.02
13.36
1.8
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
689
5122
1.37
13.32
2.8
2.8
e9/l
4.0
4.1
0.13
537
4030
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
172
931
1.86
13.20
1.2
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
293
1845
1.61
13.08
1.3
1.3
u/l
12.3
11.8
0.26
237
1516
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
699
5225
1.37
13.05
2.4
2.2
ug/l
10.1
6.6
1.90
581
4499
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
545
3914
1.42
12.92
1.6
1.5
—
—
—
0
0
(3010421) pH of Blood
266
1643
1.64
12.84
3.6
3.6
ph
7.4
7.4
1.21
233
1388
(3042936) Bacteria identified in Isolate by Culture
1187
9592
1.27
12.65
2.1
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1032
8195
1.29
12.63
2.0
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
235
1412
1.68
12.63
3.7
3.7
mmol/l
2.5
2.6
0.15
162
955
(3016502) Oxygen saturation in Arterial blood
827
6378
1.33
12.54
8.3
7.2
%
95.1
95.8
1.89
794
6129
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
377
2540
1.51
12.47
1.9
1.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
291
1853
1.59
12.41
2.4
2.0
mg/l
10.4
11.0
0.77
269
1723
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
342
2260
1.53
12.39
2.0
2.3
g/l
9.8
10.2
1.19
296
1906
(3007566) Smooth muscle Ab [Titer] in Serum
308
1991
1.57
12.32
1.2
1.2
titre
97.6
124.1
0.36
21
198
(3023323) Follitropin [Units/volume] in Serum or Plasma
600
4425
1.38
12.18
1.4
1.3
iu/l
30.8
30.2
0.15
514
3851
(3000570) Elastase.pancreatic [Mass/mass] in Stool
311
2023
1.56
12.11
1.4
1.4
ug/g
283.6
284.3
0.02
195
1140
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
161
880
1.84
12.03
1.6
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
700
5300
1.35
12.02
3.6
3.9
%
1.0
0.6
1.13
141
1155
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
324
2134
1.54
11.93
1.2
1.3
u/ml
68.8
40.9
0.64
16
141
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
83
358
2.33
11.72
1.1
1.1
u/l
14.2
23.6
2.33
58
273
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
5408
50609
1.17
11.70
3.3
3.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
304
1984
1.55
11.67
1.2
1.2
titre
1130.0
913.6
—
8
75
(3022145) Colonoscopy Study observation
1000
7992
1.28
11.60
1.3
1.3
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
83
360
2.32
11.57
1.1
1.1
u/l
65.6
80.8
2.22
60
281
(1616796) Gas panel - Central venous blood
225
1371
1.66
11.50
3.1
3.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
385
2657
1.47
11.33
3.9
3.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3131
28134
1.17
11.15
4.1
3.7
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
137
730
1.89
11.11
1.6
1.5
g/l
31.0
32.9
1.05
124
661
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
99
470
2.12
11.10
1.5
1.5
u/l
4.9
6.0
0.31
44
233
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
471
3390
1.41
11.05
10.6
9.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
410
2883
1.44
10.95
3.1
2.9
%
1.2
1.2
0.68
404
2865
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
88
402
2.20
10.88
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
227
1414
1.62
10.67
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
227
1414
1.62
10.67
1.3
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
400
2819
1.44
10.57
3.2
2.8
%
0.6
0.7
1.07
391
2711
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
477
3469
1.40
10.55
2.1
2.1
u/l
6752.3
5500.3
0.34
187
1417
(3006184) Hemoglobin [Mass/volume] in Capillary blood
232
1465
1.60
10.32
1.9
2.2
g/l
131.4
127.8
1.15
141
1051
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1476
12489
1.22
10.22
1.7
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1727
14845
1.20
10.14
1.7
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
757
5951
1.30
9.96
8.9
7.5
g/l
121.4
120.6
0.51
733
5729
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
314
2138
1.49
9.93
3.2
2.2
ug/l
350.6
636.4
1.41
292
1984
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
322
2207
1.48
9.86
1.7
1.7
g/l
0.2
0.2
0.05
299
2092
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
236
1517
1.57
9.76
1.4
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
327
2255
1.47
9.71
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
1179
9801
1.23
9.66
1.2
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
327
2267
1.46
9.46
1.7
1.7
g/l
1.2
1.2
0.32
303
2153
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
138
778
1.79
9.42
2.5
3.3
nmol/l
4.1
12.6
0.64
129
756
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1041
8561
1.24
9.42
4.6
4.1
%
33.1
32.9
0.26
750
5764
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
36
113
3.19
9.42
1.1
1.1
pmol/l
1.5
4.7
—
6
14
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
613
4725
1.32
9.33
1.2
1.3
au/ml
53.0
50.7
0.07
20
195
(3005322) IgE [Units/volume] in Serum or Plasma
625
4833
1.32
9.29
1.3
1.3
u/ml
184.4
207.6
0.39
586
4443
(3011985) Renin [Units/volume] in Plasma
152
886
1.73
9.25
1.9
1.4
mu/l
53.9
50.9
0.13
132
790
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
663
5173
1.30
9.23
2.3
2.3
au/ml
18.3
26.4
1.48
31
328
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
207
1312
1.59
9.12
1.6
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
178
1089
1.65
9.05
1.1
1.1
u/ml
3.2
3.2
0.01
79
524
(3012441) Differential panel - Pleural fluid
106
559
1.91
8.97
1.7
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
119
652
1.84
8.94
1.6
1.5
e6/l
1874.2
3129.4
0.61
91
478
(3030313) Adrenal Ab [Titer] in Serum
23
55
4.19
8.90
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1051
8718
1.23
8.76
1.6
1.6
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
87
432
2.02
8.76
1.1
1.2
u/l
19.2
21.1
0.13
70
370
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
105
557
1.90
8.74
1.1
1.3
titre
185.0
189.7
0.02
14
111
(3004451) EKG impression Narrative
67
301
2.24
8.71
1.2
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
146
857
1.72
8.70
1.5
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
243
1621
1.51
8.55
1.2
1.2
u/ml
32.3
43.0
0.60
28
184
(3021879) Hepatitis B virus core Ab [Presence] in Serum
711
5655
1.28
8.54
1.4
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
37
127
2.92
8.36
1.6
1.4
ng/l
96.3
105.8
0.24
37
127
(3022493) Free Hemoglobin [Mass/volume] in Plasma
55
232
2.38
8.29
27.9
3.9
mg/l
75.4
952.4
0.49
45
164
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
175
1092
1.61
8.27
1.5
1.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
278
1921
1.46
8.23
2.8
3.2
mg/l
28.5
40.0
2.42
229
1525
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
68
315
2.17
8.23
1.7
1.6
nmol/l
2.2
4.4
0.79
58
259
(3034860) Kappa light chains.free [Mass/volume] in Serum
278
1922
1.46
8.21
2.8
3.2
mg/l
39.2
54.2
2.13
229
1525
(3037121) Protein [Mass/volume] in Urine
323
2299
1.42
8.16
3.1
3.0
g/l
0.3
0.3
0.51
143
872
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
87
445
1.96
8.09
1.1
1.2
u/l
79.5
86.1
0.24
72
391
(3051651) Icteric interference index of Serum or Plasma
82
412
2.00
8.03
4.5
3.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
178
1125
1.59
7.99
1.9
2.2
umol/l
5.1
6.7
0.98
119
841
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
268
1854
1.46
7.91
1.2
1.3
—
—
—
0
0
(3036489) Thrombin time
367
2688
1.38
7.86
3.2
2.0
s
22.2
21.3
0.61
322
2305
(3015171) Extractable nuclear Ab [Units/volume] in Serum
416
3110
1.35
7.83
1.2
1.2
u/ml
0.4
1.3
3.04
27
294
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
206
1354
1.53
7.80
1.4
1.3
u/l
29.6
29.7
0.02
168
1115
(3003181) Sodium [Moles/volume] in Urine
180
1148
1.58
7.79
1.4
1.4
mmol/l
64.7
62.5
0.28
144
914
(3027273) Bicarbonate [Moles/volume] in Venous blood
390
2890
1.37
7.77
3.4
3.2
mmol/l
25.3
25.3
0.03
371
2811
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
269
1871
1.45
7.72
2.8
3.2
ratio
1.5
1.9
—
9
149
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
279
1954
1.44
7.72
1.2
1.3
u/ml
24.3
6.8
0.79
31
318
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
222
1487
1.51
7.70
1.4
1.7
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
162
1011
1.61
7.68
1.8
1.8
mmol/l
1.6
1.6
0.05
157
988
(3035320) C reactive protein [Mass/volume] in Body fluid
96
518
1.86
7.64
2.4
2.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
275
1926
1.44
7.62
1.2
1.3
u/ml
12.5
5.6
0.32
23
197
(3024980) IgG subclass 4 [Mass/volume] in Serum
176
1126
1.57
7.53
1.5
1.6
g/l
0.8
0.7
0.20
129
842
(40767503) Oxygen content in Capillary blood by calculation
202
1333
1.53
7.53
2.2
2.4
%
16.8
16.2
0.84
94
674
(3004616) Nuclear Ab [Presence] in Serum
145
887
1.65
7.46
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
181
1169
1.56
7.44
1.3
1.2
u/ml
4.8
3.4
0.51
74
384
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
525
4090
1.30
7.43
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
62
291
2.14
7.31
1.4
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1664
14631
1.17
7.25
1.9
1.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
395
2967
1.35
7.23
2.2
2.0
nmol/l
11.4
11.5
0.08
344
2613
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
319
2320
1.39
7.16
1.9
1.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
308
2227
1.40
7.16
3.6
2.2
%
93.5
93.4
0.01
286
2065
(3028308) Erythrocytes [#/volume] in Pleural fluid
104
589
1.77
7.10
1.6
1.5
e6/l
23389.0
62210.9
2.11
68
354
(40768806) Pleura Pathology biopsy report
105
598
1.76
7.04
1.9
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
292
2100
1.40
7.01
3.8
2.5
g/l
3.6
3.6
0.07
276
1986
(3036782) Glucose [Moles/volume] in Pleural fluid
93
513
1.82
6.94
1.5
1.4
mmol/l
6.9
6.4
1.16
86
469
(4035726)
783
6457
1.23
6.89
1.4
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
185
1223
1.52
6.88
2.6
2.9
umol/l
31.2
34.1
1.11
153
1031
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
472
3667
1.30
6.84
2.5
2.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
287
2070
1.40
6.79
4.3
2.4
%
184.9
185.7
0.05
272
1960
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
118
703
1.69
6.76
1.6
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
104
599
1.74
6.73
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
280
2015
1.40
6.72
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
172
1127
1.54
6.67
1.3
1.2
u/ml
5.9
4.1
1.15
84
466
(3029937) Albumin [Presence] in Urine by Test strip
2156
19425
1.14
6.66
4.3
4.0
estimate
0.0
0.0
0.09
837
6612
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
197
1331
1.49
6.62
1.4
1.4
u/ml
134.7
113.7
0.36
47
281
(44786800) Granulocytes/100 leukocytes in Body fluid
23
69
3.34
6.54
1.3
1.3
%
19.4
20.9
0.08
18
53
(3024891) Influenza virus A+B Ag [Presence] in Specimen
265
1901
1.41
6.49
1.2
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
537
4272
1.27
6.49
1.3
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
166
1089
1.53
6.42
1.2
1.1
%
109.5
118.7
2.64
148
989
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
210
1447
1.46
6.41
1.4
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
157
1018
1.55
6.40
1.1
1.1
iu/ml
161.6
10340.8
0.56
36
238
(3021788) Differential panel - Synovial fluid
186
1257
1.49
6.27
1.7
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
184
1242
1.49
6.24
1.5
1.6
—
—
—
0
0
(3036603) Volume of Urine
80
437
1.84
6.21
1.7
1.6
ml
2063.2
1862.1
0.56
21
86
(3005988) Vibrio sp identified in Specimen by Organism specific culture
136
861
1.59
6.17
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
136
861
1.59
6.17
1.2
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
176
1182
1.50
6.12
1.7
1.7
nmol/l
51.6
43.4
1.86
171
1145
(3042733) HLA Ab [Presence] in Serum
44
194
2.27
6.10
5.0
4.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
980
8360
1.19
6.09
1.5
1.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
71
376
1.90
6.07
1.5
1.3
u/l
10.9
12.6
0.61
64
346
(3028626) Oxygen [Partial pressure] in Capillary blood
197
1357
1.46
6.05
3.5
3.1
kpa
8.4
8.3
0.25
182
1259
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
135
860
1.58
5.98
2.3
2.1
mg/l
29.4
24.7
0.30
38
222
(3012565) Volume of 24 hour Urine
64
330
1.95
5.93
1.9
2.1
ml
1944.3
1889.6
0.17
54
298
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
296
2198
1.36
5.91
1.4
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
207
1448
1.44
5.87
1.4
1.3
u/ml
12.5
21.1
—
5
37
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
70
374
1.88
5.84
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
263
1922
1.38
5.81
1.8
1.6
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
85
484
1.76
5.78
1.4
1.4
u/l
245.3
395.6
2.24
79
458
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
205
1436
1.44
5.78
1.3
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
134
860
1.57
5.76
1.2
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
125
790
1.59
5.74
1.2
1.1
%
90.7
94.4
0.79
117
746
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
85
486
1.76
5.71
1.2
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
511
4108
1.26
5.69
3.9
4.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
228
1634
1.41
5.67
4.7
4.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
375
2902
1.30
5.66
1.6
1.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
81
459
1.77
5.62
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
118
740
1.60
5.61
4.3
3.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
96
572
1.69
5.58
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
88
512
1.73
5.57
1.7
1.5
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
11
21
5.24
5.52
1.0
1.0
u/ml
1.1
0.2
—
5
8
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
195
1367
1.44
5.50
2.6
2.4
ug/min
62.9
81.2
0.45
129
798
(3023420) DNA double strand Ab [Units/volume] in Serum
129
831
1.56
5.48
1.6
1.5
iu/ml
37.6
33.1
—
7
44
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
134
871
1.55
5.47
1.2
1.4
—
—
—
0
0
(4306422)
168
1146
1.47
5.46
1.2
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
143
946
1.52
5.40
1.3
1.2
u/l
21.8
37.4
1.75
131
811
(3024522) Salmonella sp identified in Specimen by Organism specific culture
134
874
1.54
5.40
1.2
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
101
616
1.65
5.38
1.1
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
131
851
1.55
5.37
1.4
1.3
pmol/l
305.0
282.7
0.28
105
668
(3028679) Herpes simplex virus Ab [Presence] in Serum
71
393
1.81
5.34
1.2
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
55
281
1.96
5.28
2.2
2.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
272
2032
1.35
5.27
2.6
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2867
26598
1.11
5.26
2.9
2.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
213
1532
1.40
5.22
1.5
1.4
e6/l
66.3
34.3
0.49
161
1181
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
135
889
1.53
5.22
1.2
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
213
1533
1.40
5.20
1.6
1.4
e6/l
1333.2
3479.1
0.40
174
1242
(3011648) Oxygen content in Venous blood
84
494
1.71
5.15
2.2
2.6
%
11.5
11.0
0.61
84
494
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
220
1595
1.39
5.15
1.2
1.2
u/ml
1.0
5.1
2.02
14
122
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
28
109
2.57
5.12
1.4
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
189
1338
1.42
5.08
6.5
5.5
iu/ml
223.1
806.5
1.49
31
174
(40760888) Immunoglobulin light chains.free panel - Serum
201
1439
1.41
5.07
3.0
3.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
112
712
1.58
5.07
1.4
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
193
1372
1.42
5.07
1.3
1.2
u/ml
285.1
277.6
0.14
128
873
(3023410) Appearance of Cerebral spinal fluid
112
713
1.58
5.04
1.8
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
164
1133
1.46
5.03
1.2
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
86
515
1.68
4.95
1.0
1.1
mg/l
306.7
295.2
0.73
79
463
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
163
1133
1.45
4.86
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
58
311
1.87
4.86
3.4
2.8
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
124
818
1.52
4.79
7.6
6.2
mg/l
12.0
11.8
0.28
116
760
(3023511) Choriogonadotropin [Units/volume] in Urine
245
1833
1.35
4.74
1.3
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
104
661
1.58
4.74
1.6
1.4
mosm/kgh2o
282.3
276.7
1.20
74
495
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
213
1559
1.38
4.74
1.2
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
149
1025
1.46
4.70
1.3
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
35
158
2.22
4.67
1.2
1.4
mmol/l
2.3
3.4
1.51
28
144
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
154
1069
1.45
4.64
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
617
5177
1.21
4.63
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
198
1439
1.38
4.61
1.6
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1284
11439
1.14
4.56
4.8
4.8
ug/l
2.4
2.9
0.81
1104
10246
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
268
2047
1.32
4.52
2.4
2.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
136
928
1.47
4.49
1.1
1.1
g/l
1.5
1.5
0.06
124
834
(3015235) Bicarbonate [Moles/volume] in Capillary blood
206
1521
1.36
4.38
3.2
2.8
mmol/l
24.7
24.9
0.16
183
1321
(3040151) Glucose [Moles/volume] in Capillary blood
111
731
1.52
4.36
10.3
4.9
mmol/l
7.3
7.5
0.14
89
609
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
28
119
2.36
4.31
4.2
6.7
%
67.5
71.8
0.34
22
93
(3022621) pH of Urine by Test strip
586
4930
1.20
4.29
3.5
2.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
213
1588
1.35
4.26
1.2
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
337
2676
1.27
4.25
4.5
3.7
%
48.2
48.3
0.02
332
2647
(3016018) Differential panel - Cerebral spinal fluid
116
776
1.50
4.25
1.7
1.4
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
23
90
2.56
4.20
1.3
1.5
nmol/l
4.8
485533.8
1.06
23
76
(3006270) Folate [Moles/volume] in Blood
91
580
1.57
4.15
1.1
1.1
nmol/l
380.9
373.7
0.12
74
508
(3008757) Leukocyte morphology finding [Identifier] in Blood
104
684
1.53
4.13
3.7
3.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
90
573
1.58
4.13
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
297
2331
1.28
4.13
1.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
433
3551
1.23
4.12
4.0
3.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
196
1452
1.36
4.10
1.6
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
206
1539
1.35
4.08
1.4
1.2
mmol/l
3.8
3.7
0.99
195
1453
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
99
646
1.54
4.08
1.8
1.6
—
—
—
0
0
(4094501)
232
1764
1.32
4.08
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
100
654
1.54
4.08
1.4
1.7
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
65
384
1.70
4.01
1.1
1.1
u/ml
11.8
23.7
—
5
29
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
231
1762
1.32
3.98
1.5
1.3
mg/l
629.2
509.5
0.56
217
1675
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
20
75
2.67
3.98
2.0
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
283
2220
1.28
3.96
1.2
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
85
540
1.58
3.95
1.5
1.3
mmol/l
2.2
2.0
0.70
77
506
(3020491) Glucose [Moles/volume] in Blood
82
518
1.59
3.91
1.8
1.9
mmol/l
6.7
6.4
0.40
65
374
(1002224) Polysomnography panel
355
2867
1.25
3.91
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
157
1132
1.39
3.90
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
156
1124
1.39
3.89
1.3
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
73
449
1.63
3.88
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
949
8384
1.15
3.81
1.6
1.7
%
1.4
1.4
0.90
826
7433
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
278
2188
1.28
3.81
1.2
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
408
3355
1.23
3.81
3.0
2.5
e6/l
0.2
0.3
0.22
396
3235
(4062490)
108
730
1.49
3.80
1.4
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
118
813
1.46
3.78
1.2
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
45
243
1.86
3.77
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
280
2214
1.27
3.71
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
343
2778
1.24
3.70
1.1
1.1
—
—
—
0
0
(4010399)
596
5095
1.18
3.69
1.5
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
114
785
1.46
3.67
1.9
1.8
pmol/l
181.1
185.1
0.13
98
740
(3041918) Cholesterol [Moles/volume] in Pleural fluid
24
103
2.33
3.65
1.2
1.2
mmol/l
1.5
1.8
0.66
13
61
(3003327) Ova and parasites identified in Stool by Light microscopy
330
2666
1.25
3.64
1.7
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
64
388
1.65
3.62
1.2
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
21
85
2.47
3.62
1.3
1.3
mmol/l
1.8
1.1
0.32
11
54
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
86
561
1.54
3.60
1.2
1.2
u/ml
75.6
67.6
—
5
29
(3028192) IgG subclass 2 [Mass/volume] in Serum
107
731
1.47
3.60
1.4
1.4
g/l
2.9
2.8
0.14
75
511
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
89
586
1.52
3.57
1.5
1.6
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
107
732
1.47
3.57
1.4
1.4
g/l
6.2
6.8
1.15
72
509
(3024139) IgG subclass 3 [Mass/volume] in Serum
107
732
1.47
3.57
1.4
1.4
g/l
0.4
0.4
1.10
74
507
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
20
80
2.50
3.54
1.7
1.5
%
11.7
9.2
0.14
13
44
(3009466) Valproate [Moles/volume] in Serum or Plasma
121
851
1.43
3.50
5.5
4.8
umol/l
380.6
361.6
0.84
102
738
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
86
565
1.53
3.50
1.2
1.2
u/ml
58.7
45.1
—
6
43
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
147
1070
1.38
3.49
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
755
6618
1.15
3.41
2.8
3.0
ug/l
0.8
0.8
0.23
492
4378
(3045683) HLA typing for celiac disease panel - Blood or Tissue
72
459
1.57
3.36
1.0
1.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
67
420
1.60
3.35
1.3
1.2
mmol/l
31.7
33.8
0.39
57
360
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
85
563
1.51
3.35
1.2
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
28
134
2.09
3.32
1.4
1.2
mu/l
92.4
78.7
0.11
23
101
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
24
108
2.23
3.31
1.2
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
886
7871
1.14
3.30
1.5
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
85
565
1.51
3.30
1.2
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
56
337
1.67
3.29
1.1
1.3
nmol/l
125.5
135.8
1.03
56
337
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
85
566
1.51
3.27
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
386
3210
1.21
3.27
1.2
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
318
2597
1.23
3.22
4.3
4.7
%
1.7
1.7
0.12
301
2430
(3026389) Candida sp identified in Specimen by Organism specific culture
156
1163
1.35
3.22
1.2
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
69
441
1.57
3.20
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
146
1079
1.36
3.19
2.8
2.7
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
175
1330
1.32
3.18
3.8
2.9
mmol/l
1.6
1.6
0.09
167
1299
(21494755) Public health laboratory ask at order entry panel
675
7698
0.87
3.18
1.3
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
84
563
1.50
3.15
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
84
565
1.49
3.10
1.2
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
46
268
1.72
3.07
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
69
446
1.55
3.06
1.0
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
13
45
2.89
3.02
1.2
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
43
247
1.74
3.02
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
77
512
1.51
3.01
1.2
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
80
538
1.49
2.97
1.3
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
80
538
1.49
2.97
1.3
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
80
538
1.49
2.97
1.3
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
83
563
1.48
2.96
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
104
737
1.42
2.95
3.0
2.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
173
1329
1.31
2.94
1.5
1.4
nmol/l
0.4
0.4
0.05
129
1026
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
57
356
1.60
2.94
2.7
2.6
—
31.6
—
0
7
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
122
890
1.38
2.93
1.4
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
41
235
1.75
2.91
2.4
2.3
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
34
184
1.85
2.90
1.5
1.1
%
87.9
82.8
0.28
18
42
(44790047)
103
732
1.41
2.88
1.6
1.5
—
—
—
0
0
(44806118)
103
732
1.41
2.88
1.6
1.5
—
—
—
0
0
(44790049)
103
732
1.41
2.88
1.6
1.5
—
—
—
0
0
(44790048)
103
732
1.41
2.88
1.6
1.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
30
156
1.93
2.88
1.1
1.1
pmol/l
325.8
335.9
0.03
22
114
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
130
961
1.36
2.88
1.2
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
224
1786
1.26
2.86
1.4
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
111
802
1.39
2.83
1.3
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
56
352
1.59
2.83
2.3
3.1
ph
7.4
7.4
0.08
26
120
(3016750) Collection duration of Urine
54
338
1.60
2.78
1.8
2.2
min
500.6
497.6
0.09
44
258
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
54
338
1.60
2.78
1.2
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
41
239
1.72
2.76
3.1
2.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
114
832
1.37
2.75
1.6
1.5
%
56.0
56.6
0.05
75
513
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
27
138
1.96
2.74
1.3
1.3
ug/l
8.3
330.4
1.14
17
77
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
524
4553
1.16
2.72
1.5
1.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
21
98
2.15
2.70
1.1
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
139
1050
1.33
2.69
3.8
3.3
%
1.2
1.4
0.26
108
811
(3024471) HLA-A [Type]
36
204
1.77
2.68
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
75
510
1.47
2.68
1.3
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
53
334
1.59
2.67
1.2
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
310
2581
1.21
2.66
4.4
4.7
%
0.9
0.9
0.06
292
2415
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
78
536
1.46
2.65
1.3
1.3
u/ml
0.2
1.2
1.54
41
245
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
293
2428
1.21
2.64
2.1
1.9
ug/l
6.2
2.1
0.39
255
2156
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
33
183
1.81
2.64
1.1
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
19
86
2.21
2.63
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
162
1256
1.30
2.62
1.9
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
116
857
1.36
2.61
2.6
2.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1859
17392
1.09
2.61
3.7
3.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
830
7462
1.12
2.60
3.1
3.9
ug/l
10.1
26.7
2.15
649
5895
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
46
282
1.63
2.59
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
978
8880
1.11
2.57
1.8
1.8
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
17
74
2.30
2.57
9.0
10.9
mmol/l
5.2
5.2
0.03
17
74
(3019832) Treponema pallidum Ab [Presence] in Serum
911
8241
1.12
2.56
1.6
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
72
491
1.47
2.55
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
35
200
1.75
2.55
1.0
1.1
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
5
7
7.14
2.55
1.0
1.0
mu/l
1.7
2.3
—
5
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
49
307
1.60
2.54
1.1
1.1
iu/ml
194.7
170.1
0.16
49
302
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
80
558
1.44
2.53
1.4
1.3
nmol/l
1.3
1.5
0.35
69
509
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
25
129
1.94
2.49
1.5
2.2
mmol/l
7.3
7.3
0.03
16
74
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
48
301
1.60
2.49
2.5
2.1
ug/min
179.2
93.8
—
6
67
(3042631) Mycobacterium sp identified in Specimen
113
839
1.35
2.48
2.2
2.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
147
1134
1.30
2.48
1.4
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
47
294
1.60
2.46
2.0
2.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
6594
64640
1.08
2.43
24.1
16.3
g/l
331.3
331.7
4.33
6551
64159
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
32
181
1.77
2.42
1.4
1.1
%
79.1
72.8
0.29
15
37
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
210
1702
1.24
2.38
2.9
3.3
mg/l
1.6
1.5
1.94
193
1572
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
84
599
1.41
2.37
3.8
4.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
453
3939
1.16
2.37
5.8
6.7
mmol/l
24.5
24.6
0.23
423
3662
(3045414) Leukocytes [Presence] in Urine
397
3420
1.17
2.35
2.0
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1000
9141
1.11
2.33
3.9
4.1
%
23.0
21.7
1.60
424
4371
(3038515) Glucose [Moles/volume] in Venous blood
160
1261
1.27
2.32
4.1
3.0
mmol/l
7.4
7.4
0.10
154
1234
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
379
1.51
2.31
1.2
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
56
371
1.51
2.31
2.2
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
50
323
1.55
2.31
1.3
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
50
323
1.55
2.31
1.3
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
50
323
1.55
2.31
1.3
1.9
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
20
98
2.04
2.31
1.1
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
50
324
1.55
2.28
1.3
1.9
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
12
47
2.56
2.26
3.3
2.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
204
1660
1.23
2.25
1.8
1.6
e6/l
11295.9
12622.2
0.24
150
1197
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
46
294
1.57
2.23
1.4
2.2
umol/l
120.4
142.7
0.18
21
166
(3033923) Metanephrine [Moles/time] in 24 hour Urine
27
150
1.80
2.19
1.1
1.1
umol/24h
0.6
0.7
0.94
12
69
(3010375) cycloSPORINE [Mass/volume] in Blood
45
288
1.57
2.18
28.0
27.3
ug/l
122.1
115.4
0.25
32
243
(3014051) Protein [Presence] in Urine by Test strip
214
1757
1.22
2.18
2.4
2.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
60
409
1.47
2.18
1.8
1.6
ug/l
16.5
8.6
0.56
52
364
(3004716) Salmonella sp identified in Stool by Organism specific culture
467
4100
1.15
2.17
1.4
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
134
1043
1.29
2.16
2.6
2.6
u/ml
480.0
1695.8
—
6
53
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
42
265
1.59
2.16
1.1
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
33
196
1.69
2.14
1.6
1.4
%
70.2
62.4
0.56
25
163
(3004775) Volume in Urine collected for unspecified duration
65
453
1.44
2.12
2.1
2.3
ml
602.1
655.8
0.66
53
311
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
26
145
1.80
2.09
1.1
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
56
0.00
2.06
0.0
1.0
—
—
—
0
0
(4015189)
28
161
1.74
2.05
2.4
2.3
—
—
—
0
0
(3017704) Immunofixation for Urine
46
301
1.53
2.04
2.2
1.7
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
9
32
2.81
2.00
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
19
97
1.96
1.99
1.2
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
246
2069
1.19
1.99
4.8
5.3
mmol/l
1.3
1.3
0.14
220
1827
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
46
304
1.52
1.97
1.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
46
304
1.52
1.97
1.4
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
88
657
1.34
1.94
1.1
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
10
39
2.57
1.92
1.0
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
101
772
1.31
1.91
1.1
1.1
—
3.2
—
0
8
(4268621)
102
781
1.31
1.90
2.5
2.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
28
165
1.70
1.90
1.6
1.4
%
1.9
2.4
0.18
21
141
(3025130) Human papilloma virus identified in Specimen
169
1377
1.23
1.90
1.7
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
39
251
1.56
1.88
1.0
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
51
348
1.47
1.88
1.2
1.3
%
59.9
67.7
—
7
42
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
7
22
3.18
1.88
1.3
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
41
268
1.53
1.86
1.3
2.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
72
2.09
1.86
1.3
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
289
2486
1.17
1.82
2.7
3.4
u/ml
288.6
2820.7
1.45
234
2111
(3028707) Methadone [Presence] in Urine by Screen method
143
1153
1.24
1.79
1.8
2.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
158
1288
1.23
1.79
1.6
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
82
615
1.34
1.78
1.6
1.5
%
30.8
33.2
0.21
50
366
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
40
263
1.52
1.78
1.3
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
40
263
1.52
1.78
1.3
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
39
255
1.53
1.78
1.6
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
101
781
1.30
1.77
1.1
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
68
496
1.37
1.77
2.4
2.7
e9/l
0.2
0.2
0.77
61
423
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
230
2707
0.85
1.76
2.0
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1675
15842
1.07
1.76
4.3
4.0
kg/l
1.0
1.0
0.23
312
2432
(3020874) Milk IgE Ab [Units/volume] in Serum
67
488
1.38
1.76
1.0
1.1
u/ml
0.5
2.0
1.10
18
140
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
10
41
2.44
1.75
1.2
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
18
95
1.90
1.75
1.4
1.1
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
9
36
2.50
1.73
2.2
1.9
umol/l
1.1
0.8
—
9
22
(44816559) Phosphatidylethanol [Mass/volume] in Blood
158
1294
1.22
1.72
1.2
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
67
490
1.37
1.72
1.1
1.1
ratio
1.1
1.1
0.08
24
170
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
57
406
1.41
1.71
1.3
1.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
58
415
1.40
1.70
1.2
1.3
titre
82.9
54.9
—
7
35
(40757373) Influenza virus identified in Isolate
23
133
1.73
1.69
1.8
1.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
84
639
1.32
1.68
3.5
3.3
%
59.2
56.7
0.40
56
406
(3010370) Gastrin [Moles/volume] in Serum or Plasma
19
104
1.83
1.66
2.6
1.8
pmol/l
28.4
48.3
0.90
14
92
(43055514) Macroprolactin [Presence] in Serum or Plasma
28
172
1.63
1.66
1.1
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
31
196
1.58
1.65
1.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
17
90
1.89
1.64
1.2
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
70
520
1.35
1.64
2.3
2.6
e6/l
482.9
542.6
0.61
61
427
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
151
1238
1.22
1.64
1.2
1.3
ug/l
2.5
4.0
2.53
131
1099
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
24
142
1.69
1.64
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
97
756
1.29
1.63
1.1
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
149
1222
1.22
1.62
2.4
1.9
nmol/l
0.8
0.8
0.17
121
1042
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
127
1024
1.24
1.62
1.2
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
66
490
1.35
1.57
2.3
2.7
e6/l
723.6
785.6
0.28
26
208
(40762814) Titanium [Mass/volume] in Blood
18
99
1.82
1.57
2.6
2.2
ug/l
9.0
3.7
—
6
40
(3015183) Erythrocyte sedimentation rate
57
414
1.38
1.55
1.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
57
414
1.38
1.55
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
78
595
1.31
1.55
2.6
2.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
91
709
1.29
1.55
1.2
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
159
1320
1.21
1.55
1.2
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
64
475
1.35
1.53
1.4
1.5
u/ml
27.7
21.0
—
7
95
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
36
241
1.50
1.51
1.1
1.2
%
113.0
110.9
0.20
31
214
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
6
21
2.86
1.50
3.5
11.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
114
919
1.24
1.48
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
912
8493
1.08
1.48
1.9
2.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
148
1227
1.21
1.47
1.2
1.1
au/ml
1.0
13.2
—
5
66
(3050129) First trimester maternal screen panel - Serum or Plasma
344
3051
1.13
1.47
1.5
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
26
163
1.60
1.45
1.2
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
38
2.37
1.45
1.4
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1018
9530
1.08
1.45
2.1
2.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
12
59
2.04
1.43
2.1
2.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
21
125
1.68
1.43
1.0
1.0
ug/l
72.4
75.0
0.10
15
106
(3051593) INR in Capillary blood by Coagulation assay
39
270
1.45
1.41
11.7
13.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
60
448
1.34
1.41
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
139
1152
1.21
1.40
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
161
1354
1.19
1.40
1.7
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
42
296
1.42
1.39
3.5
3.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
14
74
1.89
1.38
1.9
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
325
2885
1.13
1.38
2.4
1.6
mg/l
4.0
3.6
0.28
256
1988
(3045424) Erythrocytes [Presence] in Urine
149
1246
1.20
1.38
1.5
1.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
33
222
1.49
1.38
1.2
1.2
%
24.2
18.0
—
5
32
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
88
696
1.27
1.37
1.1
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
9
41
2.20
1.36
1.6
1.5
umol/24h
385.1
287.7
—
9
41
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
17
2.94
1.36
1.4
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
384
3450
1.12
1.34
1.4
1.4
—
—
—
0
0
(4024509)
90
716
1.26
1.34
1.7
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
132
1097
1.21
1.32
1.7
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
121
997
1.22
1.31
1.7
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
24
152
1.58
1.31
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
262
2304
1.14
1.31
1.6
1.6
iu/ml
0.0
2.9
0.63
50
498
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
6
24
2.50
1.30
1.0
1.1
nmol/l
201.0
262.4
—
6
24
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
14
76
1.84
1.29
1.3
1.3
u/l
27.8
415.6
—
8
56
(3009015) Lactate [Moles/volume] in Synovial fluid
14
76
1.84
1.29
1.2
1.2
mmol/l
7.6
6.4
—
5
43
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
57
429
1.33
1.29
1.7
1.5
u/l
5.0
5.5
0.62
44
364
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
97
783
1.24
1.28
2.0
2.2
pg
32.4
32.7
0.27
97
775
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
5
18
2.78
1.28
1.0
1.0
g/l
0.2
0.2
—
5
10
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
910
8534
1.07
1.26
7.5
6.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
297
2642
1.13
1.25
1.4
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
25
162
1.54
1.25
1.2
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
76
599
1.27
1.24
1.9
2.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
13
70
1.86
1.23
1.1
1.1
umol/24h
1.5
1.7
0.73
13
70
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
13
70
1.86
1.23
2.0
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
43
312
1.38
1.23
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
69
539
1.28
1.21
1.8
2.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
8
37
2.16
1.21
1.0
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
38
271
1.40
1.21
1.2
1.1
%
81.4
94.3
0.79
18
111
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
22
140
1.57
1.19
1.2
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
101
1.68
1.19
1.4
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
97
791
1.23
1.19
2.2
2.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
245
2162
1.14
1.19
1.5
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
86
1.75
1.18
5.3
4.8
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
33
0.00
1.16
0.0
8.8
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
48
359
1.34
1.16
1.1
1.0
%
92.4
93.0
0.06
36
289
(3037556) Urate [Mass/volume] in Serum or Plasma
27
182
1.48
1.15
1.4
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
59
456
1.30
1.14
1.4
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
20
126
1.59
1.14
1.3
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
46
343
1.34
1.14
1.3
3.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
48
361
1.33
1.12
3.0
3.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
32
225
1.42
1.11
2.3
2.8
umol/l
29.3
28.6
0.13
20
171
(3038071) Oxygen [Partial pressure] in Mixed venous blood
19
119
1.60
1.11
5.3
7.4
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
38
276
1.38
1.11
1.2
1.1
%
84.5
92.5
0.54
17
107
(3012494) Peanut IgE Ab [Units/volume] in Serum
33
234
1.41
1.10
1.0
1.1
u/ml
0.3
2.2
1.44
13
127
(4146454)
79
637
1.24
1.10
3.3
2.5
—
—
—
0
0
(4133840)
10
182
0.55
1.09
1.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
68
539
1.26
1.09
1.1
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
441
4804
0.91
1.09
1.5
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
25
168
1.49
1.09
1.2
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
34
243
1.40
1.09
1.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
12
66
1.82
1.08
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
27
185
1.46
1.08
1.0
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
64
505
1.27
1.07
1.1
1.1
iu/ml
13.4
9.0
0.33
13
129
(3020891) Body temperature
279
2502
1.12
1.07
4.5
4.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
36
261
1.38
1.07
1.1
1.2
g/l
0.3
0.3
0.76
29
207
(3011412) CD3 cells [#/volume] in Blood
88
721
1.22
1.06
2.2
2.5
e9/l
1.4
1.2
0.41
53
437
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
33
2.12
1.05
1.3
1.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
21
137
1.53
1.05
1.5
1.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
30
212
1.42
1.03
2.0
2.1
e6/l
236.2
200.5
0.19
21
110
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
32
229
1.40
1.03
1.3
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
34
2.06
1.02
1.1
2.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
7
34
2.06
1.02
1.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
75
1.73
1.02
1.3
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
19
122
1.56
1.02
1.6
2.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
40
298
1.34
1.02
1.4
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
40
298
1.34
1.02
1.4
1.5
—
—
—
0
0
(3025315) Body weight
10
53
1.89
1.01
4.2
3.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
274
2465
1.12
1.01
1.3
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
138
1186
1.17
1.00
1.1
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
166
1447
1.15
1.00
5.4
6.2
mmol/l
11.9
11.2
1.32
150
1294
(40758292) HTLV I+II Ab panel - Serum
5
108
0.46
1.00
1.2
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
12
68
1.77
1.00
1.9
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
12
68
1.77
1.00
1.1
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
166
1448
1.15
0.99
5.4
6.2
mmol/l
105.1
105.1
0.03
150
1295
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
273
2458
1.11
0.99
1.3
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
13
76
1.71
0.98
1.4
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
274
2469
1.11
0.98
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
274
2471
1.11
0.97
1.4
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
74
603
1.23
0.96
1.1
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
19
124
1.53
0.96
4.3
5.0
u/l
31.8
43.1
—
9
41
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
49
380
1.29
0.96
2.3
2.8
%
44.5
40.6
1.20
21
141
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
45
346
1.30
0.94
1.1
1.1
miu/ml
1543.2
1484.4
0.12
45
346
(3029396) Erythrocyte agglutination [Presence] in Blood
33
242
1.36
0.94
2.5
3.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
14
85
1.65
0.94
3.2
3.0
u/field
0.8
0.8
0.02
14
85
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
20
133
1.50
0.94
6.2
7.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
665
7075
0.94
0.93
1.7
1.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
38
286
1.33
0.92
1.2
1.2
—
—
—
0
0
(4034850)
215
2404
0.89
0.92
12.5
8.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
24
167
1.44
0.91
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
45
348
1.29
0.91
1.6
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
76
626
1.22
0.91
1.5
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
42
322
1.31
0.90
1.0
1.1
—
—
—
0
0
(4211845)
50
393
1.27
0.90
3.0
3.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
11
63
1.75
0.90
1.5
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
210
1.38
0.90
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
24
168
1.43
0.89
1.2
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
81
674
1.20
0.88
1.4
1.4
mmol/l
14.5
11.7
1.17
26
145
(3034891) Synovial lining cells/100 cells in Synovial fluid
42
324
1.30
0.87
1.6
1.4
%
4.9
3.7
0.25
12
62
(3002523) Influenza virus A Ag [Presence] in Specimen
136
1184
1.15
0.87
1.1
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
43
1.86
0.87
1.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
8
43
1.86
0.87
1.1
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
35
264
1.33
0.85
1.1
1.1
ng/l
207.6
773.7
—
8
54
(3024869) Neuronal Ab [Presence] in Serum
18
120
1.50
0.85
1.2
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
18
120
1.50
0.85
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
18
120
1.50
0.85
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
18
120
1.50
0.85
1.0
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
45
1.78
0.84
1.1
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
25
179
1.40
0.83
1.3
1.4
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
10
57
1.76
0.83
1.2
1.0
—
3.1
—
0
8
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
48
380
1.26
0.83
2.3
1.8
u/field
1.0
2.3
2.70
35
267
(3051101) Glucose [Moles/volume] in Cord blood
6
114
0.53
0.82
6.0
6.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
18
121
1.49
0.82
1.8
1.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
29
387
0.75
0.81
21.8
11.9
nmol/l
826.9
834.4
0.03
29
369
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
36
276
1.31
0.80
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
34
259
1.31
0.79
1.2
1.1
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
8
48
1.67
0.78
1.3
1.1
mmol/l
8.7
8.0
—
8
48
(3018405) Lactate [Moles/volume] in Arterial blood
243
2210
1.10
0.78
3.6
3.9
mmol/l
1.2
1.4
1.38
238
2169
(3013862) HLA-DP [Type]
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
58
476
1.22
0.75
1.0
1.0
u/ml
10.6
1.0
0.44
12
110
(3008401) Mugwort IgE Ab [Units/volume] in Serum
149
1322
1.13
0.75
1.1
1.1
u/ml
0.5
1.0
2.07
57
531
(21494814) CD8 cells/100 lymphocytes in Specimen
22
302
0.73
0.75
1.7
2.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
13
83
1.57
0.74
2.8
2.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
554
5222
1.06
0.74
3.2
3.5
u/ml
66.2
59.4
0.15
530
5051
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
43
342
1.26
0.74
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
62
514
1.21
0.73
1.1
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
5
25
2.00
0.72
1.2
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
56
461
1.22
0.72
1.2
1.3
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
12
76
1.58
0.71
1.7
2.8
mg/l
3.6
1.0
—
7
54
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
41
326
1.26
0.71
1.2
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
29
220
1.32
0.71
2.0
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
154
1379
1.12
0.69
1.1
1.1
u/ml
4.0
5.0
0.46
82
700
(40765096) Chromosome analysis panel by Banding
11
169
0.65
0.68
1.2
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
43
346
1.24
0.68
1.8
1.6
nmol/l
1.2
1.3
0.45
32
270
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(4212803)
10
61
1.64
0.68
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1685
16362
1.04
0.68
1.5
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
39
311
1.26
0.67
1.7
2.4
—
—
—
0
0
(44806071)
15
102
1.47
0.67
1.1
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
32
249
1.29
0.67
1.7
1.5
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
7
43
1.63
0.66
1.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
34
267
1.27
0.66
1.1
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
54
449
1.20
0.64
1.3
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
49
1.63
0.62
1.4
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
69
590
1.17
0.61
1.2
1.1
mg/l
38.6
39.9
0.09
54
493
(40768795) Lymph node Pathology biopsy report
87
758
1.15
0.61
1.1
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
211
1937
1.09
0.61
1.8
1.8
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
19
139
1.37
0.60
1.6
1.9
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
21
157
1.34
0.59
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
60
510
1.18
0.58
1.1
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
64
1.56
0.58
1.0
1.0
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
10
64
1.56
0.58
1.3
1.6
mmol/l
122.8
161.2
—
10
56
(1001926) Buprenorphine [Presence] in Urine by Screen method
226
2088
1.08
0.57
1.7
2.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
27
211
1.28
0.57
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
29
229
1.27
0.56
1.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
87
0.57
0.56
1.0
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
263
2448
1.08
0.56
2.0
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
14
195
0.72
0.56
1.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
22
168
1.31
0.54
1.0
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
11
74
1.49
0.53
2.8
1.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
12
83
1.45
0.51
1.3
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
14
100
1.40
0.51
3.1
2.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
78
686
1.14
0.51
1.2
1.4
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
41
1.46
0.50
7.0
3.9
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
167
1536
1.09
0.49
1.1
1.1
u/ml
2.2
1.3
0.36
62
581
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
67
1.49
0.49
1.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
36
298
1.21
0.48
2.1
2.3
umol/l
52.2
52.8
0.05
27
252
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
56
483
1.16
0.48
1.9
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
40
335
1.19
0.48
2.8
1.6
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
154
1.30
0.48
1.2
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
175
1616
1.08
0.48
1.5
1.5
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
10
68
1.47
0.47
1.9
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
19
146
1.30
0.46
1.2
1.5
g/l
15.8
12.9
0.72
14
117
(3019768) Coxiella burnetii Ab [Presence] in Serum
7
48
1.46
0.46
1.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
22
173
1.27
0.46
1.1
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
27
218
1.24
0.46
2.9
3.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
612
5883
1.04
0.46
1.8
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
232
2171
1.07
0.46
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
139
1276
1.09
0.45
1.1
1.1
u/ml
2.0
1.7
0.16
24
320
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
87
780
1.12
0.44
1.1
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
71
629
1.13
0.44
1.4
1.4
e6/l
98827.9
80874.2
0.10
48
434
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
7
51
1.37
0.44
3.9
6.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
18
139
1.30
0.43
1.1
1.1
—
240.0
—
0
8
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
31
1.61
0.43
1.0
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
95
0.63
0.42
1.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
13
96
1.35
0.41
1.0
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
9.8
4.4
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
15
0.00
0.41
0.0
1.2
—
69.6
—
0
15
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(4027681)
52
454
1.15
0.40
1.3
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
242
2281
1.06
0.40
1.4
1.4
pmol/l
227.7
146.7
0.49
236
2218
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
5.8
—
4.2
—
0
11
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
78
700
1.12
0.40
1.6
1.6
mmol/l
7.7
7.7
0.00
53
422
(3041672) Baker's yeast Ab [Presence] in Serum
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
65
577
1.13
0.40
1.1
1.1
mg/l
237.9
244.6
0.12
54
510
(40768446) Kidney Pathology biopsy report
29
241
1.20
0.40
1.5
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
197
1847
1.07
0.39
2.0
3.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
35
1.43
0.39
1.6
2.5
—
—
—
0
0
(44806420)
14
182
0.77
0.39
3.1
2.4
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
36
1.39
0.38
1.4
1.6
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
35
298
1.18
0.38
1.5
1.5
iu/ml
—
1875307.6
—
0
17
(3044009) aPTT.lupus sensitive (LA screen)
9
67
1.34
0.38
1.1
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
68
609
1.12
0.37
2.5
2.7
mg/l
29.3
41.1
0.37
43
427
(3020393) Adenovirus Ag [Presence] in Stool
10
72
1.39
0.36
1.0
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
18
143
1.26
0.36
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
263
2499
1.05
0.35
1.6
2.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
46
404
1.14
0.35
1.1
1.0
u/l
1.2
1.1
0.46
21
184
(40768800) Prostate Pathology biopsy report
64
711
0.90
0.34
1.2
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
44
1.36
0.34
1.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
19
154
1.23
0.33
1.2
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
43
379
1.14
0.32
1.2
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
32
369
0.87
0.31
1.3
1.3
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
52
1.35
0.31
1.0
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
176
1664
1.06
0.30
2.9
3.6
u/ml
27.1
35.8
0.56
171
1613
(42529582) MDA5 Ab [Presence] in Serum by Line blot
22
184
1.20
0.30
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
22
184
1.20
0.30
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
22
184
1.20
0.30
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
22
184
1.20
0.30
1.0
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
44
391
1.13
0.29
2.2
2.0
ug/l
3.2
3.4
0.13
38
343
(3043238) Trisomy 21 risk [Likelihood] in Fetus
218
2077
1.05
0.29
1.4
1.5
—
—
—
0
0
(44813793)
61
554
1.10
0.29
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
20
167
1.20
0.28
1.1
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
63
1.27
0.27
1.0
1.1
—
—
—
0
0
(4281824)
95
1020
0.93
0.27
1.1
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
38
337
1.13
0.27
1.9
2.3
umol/l
14.7
18.9
—
7
33
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
12
95
1.26
0.26
6.6
6.6
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
24
206
1.17
0.26
1.2
1.3
g/l
41.9
38.7
0.82
16
109
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
50
453
1.10
0.25
1.2
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
72
1.25
0.25
1.3
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
74
1.22
0.25
1.2
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
76
1.18
0.24
1.4
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
9
76
1.18
0.24
1.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
23
198
1.16
0.24
2.7
3.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
23
198
1.16
0.24
2.7
3.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
198
1895
1.05
0.24
3.9
4.1
mmol/l
3.9
3.8
0.16
185
1779
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
61
561
1.09
0.24
2.2
2.0
u/field
2.2
2.1
0.15
33
229
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
6
85
0.71
0.24
8.7
8.0
umol/l
0.3
0.4
—
6
80
(3047352) Trisomy 18 risk [Likelihood] in Fetus
211
2024
1.04
0.23
1.4
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
19
162
1.17
0.22
1.3
2.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
210
2017
1.04
0.22
1.3
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
160
1527
1.05
0.22
3.3
3.3
mg/l
22.9
26.3
0.57
83
962
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
469
4570
1.03
0.22
1.7
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
13
157
0.83
0.22
1.2
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
7
94
0.74
0.22
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
282
2727
1.04
0.22
1.6
2.1
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
0
12
0.00
0.21
0.0
6.1
—
56.4
—
0
5
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
12
98
1.22
0.21
1.3
1.4
%
44.5
60.4
—
6
47
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
8
105
0.76
0.21
2.3
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
99
1048
0.94
0.21
1.1
1.1
u/ml
3.4
3.8
0.07
35
424
(3036180) Methadone [Presence] in Urine
0
13
0.00
0.21
0.0
2.8
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
64
595
1.08
0.20
1.9
2.1
%
74.7
73.3
0.34
58
572
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
14
0.00
0.20
0.0
1.1
—
37.5
—
0
14
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
16
136
1.18
0.20
2.0
1.3
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
50
1.20
0.19
1.0
1.2
u/l
46.8
8.9
—
6
50
(3047189) Immunofixation for 24 hour Urine
30
269
1.12
0.19
2.3
1.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
27
241
1.12
0.19
1.8
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
16
137
1.17
0.18
1.1
2.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
53
1.13
0.18
1.7
2.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
21
238
0.88
0.18
1.5
2.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
31
280
1.11
0.18
1.3
1.4
pmol/l
107.1
152.4
0.18
17
95
(3010937) Rubella virus Ab [Presence] in Serum
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
7
58
1.21
0.18
1.3
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
62
580
1.07
0.18
1.9
2.1
%
11.6
13.3
0.87
37
272
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
7
59
1.19
0.18
10.4
7.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
26
233
1.12
0.17
1.5
2.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
63
1.11
0.17
1.3
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
319
3272
0.97
0.17
1.4
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
282
2745
1.03
0.16
1.6
2.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
41
379
1.08
0.16
2.4
2.1
ug/l
2.1
2.5
0.42
34
325
(3020650) Glucose [Presence] in Urine
18
204
0.88
0.16
1.2
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
287
2797
1.03
0.16
1.4
1.3
miu/ml
246.4
232.2
0.27
141
1361
(3042517) Benzodiazepines panel - Urine
8
72
1.11
0.16
3.4
2.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
23
206
1.12
0.16
1.7
1.6
ug/l
9.8
8.5
0.55
23
206
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
6
76
0.79
0.15
1.5
3.1
umol/l
29.0
40.5
—
6
67
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
140
0.86
0.15
1.4
2.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
145
1399
1.04
0.15
2.9
3.2
u/ml
1037.1
524.7
0.33
136
1270
(3014133) Dog dander IgE Ab [Units/volume] in Serum
107
1116
0.96
0.15
1.1
1.1
u/ml
3.1
4.3
0.32
32
425
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
21
188
1.12
0.14
2.4
3.2
ng/l
60.1
122.3
—
8
79
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
192
0.89
0.14
1.1
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
19
169
1.12
0.14
1.5
2.2
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
15
131
1.15
0.14
1.4
1.3
—
211.1
—
0
21
(3028300) Cannabinoids [Presence] in Urine
282
2754
1.02
0.14
1.6
2.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
56
528
1.06
0.14
1.4
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
8
96
0.83
0.13
1.1
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
21
189
1.11
0.13
1.3
2.0
e6/l
3357.3
21485.4
—
10
101
(40761535) Cells panel - Urine sediment
570
5615
1.02
0.13
3.8
3.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
9
110
0.82
0.13
6.3
6.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
96
923
1.04
0.12
2.5
2.4
u/ml
204.0
1721.9
0.77
91
863
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
15
133
1.13
0.12
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
14
124
1.13
0.11
2.6
1.9
umol/l
18.4
16.7
0.21
14
124
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
12
105
1.14
0.11
2.4
2.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
27
251
1.08
0.10
1.7
2.5
au/ml
222.6
100.3
—
5
38
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
14
125
1.12
0.10
1.1
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
12
106
1.13
0.09
1.5
2.8
—
21.3
—
0
18
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
73
704
1.04
0.09
1.5
1.6
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
6
56
1.07
0.08
1.0
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
57
1.05
0.08
5.3
2.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
50
479
1.04
0.08
1.2
1.5
promille
1.4
1.2
0.47
40
369
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
17
185
0.92
0.08
1.4
1.8
ug/l
3.4
2.4
—
9
105
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
275
2710
1.02
0.08
1.6
2.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
7
68
1.03
0.07
1.1
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
75
0.80
0.07
1.7
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
57
550
1.04
0.07
1.1
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
580
5753
1.01
0.06
2.8
2.5
ml/min/173m2
64.6
68.6
1.63
250
2204
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
9
105
0.86
0.06
1.1
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
40
416
0.96
0.06
1.0
1.0
ng/l
256.1
357.3
1.43
30
296
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
41
424
0.97
0.05
1.2
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
34
353
0.96
0.04
1.8
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
20
189
1.06
0.04
2.1
1.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
61
595
1.03
0.04
1.9
2.3
%
49.8
43.2
—
6
78
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
90
916
0.98
0.04
1.0
1.0
u/ml
0.1
0.3
0.93
16
198
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
45
462
0.97
0.03
1.2
1.1
—
—
—
0
0
(4198724)
30
290
1.03
0.03
1.6
3.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
51
499
1.02
0.03
1.9
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
12
128
0.94
0.02
2.1
1.5
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
41
420
0.98
0.02
1.0
1.0
ng/l
606.0
718.7
1.22
29
294
(3045716) Anion gap in Serum or Plasma
30
291
1.03
0.02
2.4
2.5
mmol/l
10.1
9.2
0.72
22
221
(3005082) Progesterone [Moles/volume] in Serum or Plasma
51
500
1.02
0.02
1.3
1.4
nmol/l
24.7
32.6
1.62
46
462
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
112
1131
0.99
0.02
1.4
1.3
mmol/l
7.1
7.1
0.00
81
823
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
12
113
1.06
0.01
1.3
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
29
283
1.02
0.01
3.6
4.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
15
156
0.96
0.00
1.3
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
18
186
0.97
0.00
1.5
2.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
10
97
1.03
0.00
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
19
194
0.98
0.00
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
77
766
1.01
0.00
1.1
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
109
1086
1.00
0.00
1.2
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
26
265
0.98
0.00
2.0
3.1
mg/l
8.0
7.8
0.07
21
203
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
42
425
0.99
0.00
2.0
1.9
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
102
0.98
0.00
3.4
2.8
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
22
218
1.01
0.00
1.5
2.2
e6/l
659.1
3003.3
0.53
14
152
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
42
422
1.00
0.00
1.0
1.0
ng/l
33.7
45.9
1.87
31
295
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
12
119
1.01
0.00
1.2
1.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
6
59
1.02
0.00
2.5
3.2
g/mol
72.0
35.1
—
6
50
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
78
0.90
0.00
1.0
1.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
22
220
1.00
0.00
1.0
1.1
—
8.7
—
0
35
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000219) Insulin receptor Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: E4_THYTOXNAS – Thyrotoxicosis, other and/or unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).